Download Taussig Cancer Institute 2008 Publications

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Transcript
Taussig Cancer Institute 2008 Publications
Journal Publications
Abdullah KG, Li L, Shen GQ, Hu Y, Yang Y, Mackinlay KG, Topol EJ, Wang QK. Four SNPS on
chromosome 9p21 confer risk to premature, familial CAD and MI in an American Caucasian
Population (GeneQuest). Ann Hum Genet. 2008 Sep;72(Pt 5):654-657.
Abouassaly R, Lane BR, Novick AC. Active surveillance of renal masses in elderly patients. J
Urol. 2008 Aug;180(2):505-508; discussion 508-509.
Adelstein DJ. Redefining the role of induction chemotherapy in head and neck cancer. J Clin
Oncol. 2008 Jul 1;26(19):3117-3119.
Adelstein DJ, Rodriguez CP. Current and emerging standards of concomitant
chemoradiotherapy. Semin Oncol. 2008 Jun;35(3):211-220.
Advani AS, Rodriguez C, Jin T, Jawde RA, Saber W, Baz R, Kalaycio M, Sobecks R, Sekeres M,
Tripp B, Hsi E. Increased C-kit intensity is a poor prognostic factor for progression-free and
overall survival in patients with newly diagnosed AML. Leuk Res. 2008 Jun;32(6):913-918.
Advani AS, Jin T, Ramsingh G, Tiu R, Saber W, Theil K, Sobecks R, Sekeres M, Copelan E,
Sungren S, Tripp B, Kalaycio M. Time to post-remission therapy is an independent prognostic
factor in adults with acute lymphoblastic leukemia. Leuk Lymphoma. 2008 Aug;49(8):1560-1566.
Afable MG II, Lyon DE. Severe fatigue: could it be aplastic anemia? Clin J Oncol Nurs. 2008
Aug;12(4):569-573.
Ahuja R, Yammani R, Bauer JA, Kalra S, Seetharam S, Seetharam B. Interactions of cubilin with
megalin and the product of the amnionless gene (AMN): effect on its stability. Biochem J. 2008
Mar 1;410(2):301-308.
Ahvenainen T, Lehtonen HJ, Lehtonen R, Vahteristo P, Aittomaki K, Baynam G, Dommering C,
Eng C, Gruber SB, Gronberg H, Harvima R, Herva R, Hietala M, Kujala M, Kaariainen H, Sunde
L, Vierimaa O, Pollard PJ, Tomlinson IPM, Bjorck E, Aaltonen LA, Launonen V. Mutation
screening of fumarate hydratase by multiplex ligation-dependent probe amplification: detection of
exonic deletion in a patient with leiomyomatosis and renal cell cancer. Cancer Genet Cytogenet.
2008 Jun;183(2):83-88.
Alhopuro P, Phichith D, Tuupanen S, Sammalkorpi H, Nybondas M, Saharinen J, Robinson JP,
Yang Z, Chen LQ, Orntoft T, Mecklin JP, Jarvinen H, Eng C, Moeslein G, Shibata D, Houlston
RS, Lucassen A, Tomlinson IP, Launonen V, Ristimaki A, Arango D, Karhu A, Sweeney HL,
Aaltonen LA. Unregulated smooth-muscle myosin in human intestinal neoplasia. Proc Natl Acad
Sci U S A. 2008 Apr 8;105(14):5513-5518.
Almhanna K, Pelley RJ, Budd GT, Davidson J, Moore HCF. Subcutaneous implantable venous
access device erosion through the skin in patients treated with anti-vascula endothelial growth
factor therapy: a case series. Anticancer Drugs. 2008 Feb;19(2):217-219.
Almhanna K, Kim R. Second-line therapy for gemcitabine-refractory pancreatic cancer: is there a
standard? Oncology (Williston Park). 2008 Sep;22(10):1176-1183.
Angelov L. Stereotactic spine radiosurgery. Spinal Column. 2008 Spring;14-15.
Asosingh K, Aldred MA, Vasanji A, Drazba J, Sharp J, Farver C, Comhair SAA, Xu W, Licina L,
Huang L, Anand-Apte B, Yoder MC, Tuder RM, Erzurum SC. Circulating angiogenic precursors
in idiopathic pulmonary arterial hypertension. Am J Pathol. 2008 Mar;172(3):615-627.
Assie G, LaFramboise T, Platzer P, Eng C. Frequency of germline genomic homozygosity
associated with cancer cases. JAMA. 2008 Mar 26;299(12):1437-1445.
Assie G, LaFramboise T, Platzer P, Bertherat J, Stratakis CA, Eng C. SNP arrays in
heterogeneous tissue: highly accurate collection of both germline and somatic genetic information
from unpaired single tumor samples. Am J Hum Genet. 2008 Apr;82(4):903-915.
Aucejo FN, Hashimoto K, Quintini C, Kelly D, Vogt D, Winans C, Eghtesad B, Baker M, Fung J,
Miller C. Triple-phase computed tomography and intraoperative flow measurements improve the
management of portosystemic shunts during liver transplantation. Liver Transpl. 2008
Jan;14(1):96-99.
Aydin H, Zhou M. The changing face of renal cell carcinoma pathology. Curr Oncol Rep. 2008
May;10(3):235-244.
Aytekin M, Comhair SAA, de la Motte C, Bandyopadhyay SK, Farver CF, Hascall VC, Erzurum
SC, Dweik RA. High levels of hyaluronan in idiopathic pulmonary arterial hypertension. Am J
Physiol Lung Cell Mol Physiol. 2008 Nov;295(5):L789-L799.
Bae SI, Cheriyath V, Jacobs BS, Reu FJ, Borden EC. Reversal of methylation silencing of
Apo2L/TRAIL receptor 1 (DR4) expression overcomes resistance of SK-MEL-3 and SK-MEL-28
melanoma cells to interferons (IFNs) or Apo2L/TRAIL. Oncogene. 2008 Jan 17;27(4):490-498.
Baker ME, Einstein DM, Veniero JC. Computed tomography enterography and magnetic
resonance enterography: The future of small bowel imaging. Clin Colon Rectal Surg. 2008
Aug;21(3):193-212.
Baker ME. Imaging and interventional techniques in acute left-sided diverticulitis. J Gastrointest
Surg. 2008 Aug;12(8):1314-1317.
Balmaceda C, Peereboom D, Pannullo S, Cheung YKK, Fisher PG, Alavi J, Sisti M, Chen J, Fine
RL. Multi-institutional phase II study of temozolomide administered twice daily in the treatment of
recurrent high-grade gliomas. Cancer. 2008 Mar 1;112(5):1139-1146.
Banerjee AK. Response to "Non-segmented negative-strand RNA virus RNA synthesis in vivo".
Virology. 2008 Feb 20;371(2):231-233.
Bao S, Wu Q, Li Z, Sathornsumetee S, Wang H, McLendon RE, Hjelmeland AB, Rich JN.
Targeting cancer stem cells through L1CAM suppresses glioma growth. Cancer Res. 2008 Aug
1;68(15):6043-6048.
Bartholomew JR. Heparin-induced thrombocytopenia: 2008 update. Curr Treat Options
Cardiovasc Med. 2008 Apr;10(2):117-127.
Batra PS, Kanowitz SJ, Citardi MJ. Clinical utility of intraoperative volume computed tomography
scanner for endoscopic sinonasal and skull base procedures. Am J Rhinol. 2008 Sep;22(5):511515.
Batra PS, Lanza DC. Endoscopic power-assisted orbital exenteration: A novel technique.
Operative Techniques in Otolaryngology--Head and Neck Surgery. 2008 Sep;19(3):202-204.
Batra PS, Yappel-Sinkko K, Bena J, Leong JL, Citardi MJ, Lanza DC. Prospective analysis of
epicutaneous testing for inhalant allergy: Comparison of arm and back subsites with mRAST.
Otolaryngol Head Neck Surg. 2008 Mar;138(3):328-333.
Beadling C, Jacobson-Dunlop E, Hodi FS, Le C, Warrick A, Patterson J, Town A, Harlow A, Cruz
F III, Azar S, Rubin BP, Muller S, West R, Heinrich MC, Corless CL. KIT gene mutations and
copy number in melanoma subtypes. Clin Cancer Res. 2008 Nov 1;14(21):6821-6828.
Begelman SM, Baghdasarian SB, Singh IM, Militello MA, Hursting MJ, Bartholomew JR.
Argatroban anticoagulation in intensive care patients: effects of heart failure and multiple organ
system failure. J Intensive Care Med. 2008 Sep;23(5):313-320.
Belderbos JSA, Kepka L, Kong FM, Martel MK, Videtic GMM, Jeremic B. Report from the
International Atomic Energy Agency (IAEA) consultants' meeting on elective nodal irradiation in
lung cancer: non-small-Cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys. 2008 Oct
1;72(2):335-342.
Bennani-Baiti N, Davis MP. Review article: cytokines and cancer anorexia cachexia syndrome.
Am J Hosp Palliat Care. 2008 Oct;25(5):407-411.
Berk L, James J, Schwartz A, Hug E, Mahadevan A, Samuels M, Kachnic L. A randomized,
double-blind, placebo-controlled trial of a beta-hydroxyl beta-methyl butyrate, glutamine, and
arginine mixture for the treatment of cancer cachexia (RTOG 0122). Support Care Cancer. 2008
Oct;16(10):1179-1188.
Bertolotti P, Bilotti E, Colson K, Curran K, Doss D, Faiman B, Gavino M, Jenkins B, Lilleby K,
Love G, Mangan PA, McCullagh E, Miceli T, Miller K, Rogers K, Rome S, Sandifer S, Smith LC,
Tariman JD, Westphal J. Management of side effects of novel therapies for multiple myeloma:
consensus statements developed by the International Myeloma Foundation's Nurse Leadership
Board. Clin J Oncol Nurs. 2008 Jun;12(3 Suppl):9-12.
Bianchi LK, Burke CA. Understanding current guidelines for colorectal cancer screening: A casebased approach. Cleve Clin J Med. 2008 Jun;75(6):441-448.
Bianchi LK, Burke CA, Bennett AE, Lopez R, Hasson H, Church JM. Fundic gland polyp
dysplasia is common in familial adenomatous polyposis. Clin Gastroenterol Hepatol. 2008
Feb;6(2):180-185.
Bishop MR, Dean RM, Steinberg SM, Odom J, Pavletic SZ, Chow C, Pittaluga S, Sportes C,
Hardy NM, Gea-Banacloche J, Kolstad A, Gress RE, Fowler DH. Clinical evidence of a graftversus-lymphoma effect against relapsed diffuse large B-cell lymphoma after allogeneic
hematopoietic stem-cell transplantation. Ann Oncol. 2008 Nov;19(11):1935-1940.
Bishop MR, Logan BR, Gandham S, Bolwell BJ, Cahn JY, Lazarus HM, Litzow MR, Marks DI,
Wiernik PH, McCarthy PL, Russell JA, Miller CB, Sierra J, Milone G, Keating A, Loberiza FR Jr,
Giralt S, Horowitz MM, Weisdorf DJ. Long-term outcomes of adults with acute lymphoblastic
leukemia after autologous or unrelated donor bone marrow transplantation: a comparative
analysis by the National Marrow Donor Program and Center for International Blood and Marrow
Transplant Research. Bone Marrow Transplant. 2008 Apr;41(7):635-642.
Blanke CD, Rankin C, Demetri GD, Ryan CW, von Mehren M, Benjamin RS, Raymond AK,
Bramwell VHC, Baker LH, Maki RG, Tanaka M, Hecht JR, Heinrich MC, Fletcher CDM, Crowley
JJ, Borden EC. Phase III randomized, intergroup trial assessing imatinib mesylate at two dose
levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the
kit receptor tyrosine kinase: S0033. J Clin Oncol. 2008 Feb 1;26(4):626-632.
Boffa DJ, Sands MJ, Rice TW, Murthy SC, Mason DP, Geisinger MA, Blackstone EH. A critical
evaluation of a percutaneous diagnostic and treatment strategy for chylothorax after thoracic
surgery. Eur J Cardiothorac Surg. 2008 Mar;33(3):435-439.
Borden EC, Kluger H, Crowley J. Apoptosis: a clinical perspective. Nat Rev Drug Discov. 2008
Dec;7(12):959.
Boyiadzis M, Memon S, Carson J, Allen K, Szczepanski MJ, Vance BA, Dean R, Bishop MR,
Gress RE, Hakim FT. Up-regulation of NK cell activating receptors following allogeneic
hematopoietic stem cell transplantation under a lymphodepleting reduced intensity regimen is
associated with elevated IL-15 levels. Biol Blood Marrow Transplant. 2008 Mar;14(3):290-300.
Brodsky RA, Young NS, Antonioli E, Risitano AM, Schrezenmeier H, Schubert J, Gaya A, Coyle
L, de Castro C, Fu CL, Maciejewski JP, Bessler M, Kroon HA, Rother RP, Hillmen P. Multicenter
phase 3 study of the complement inhibitor eculizumab for the treatment of patients with
paroxysmal nocturnal hemoglobinuria. Blood. 2008 Feb 15;111(4):1840-1847.
Buatti J, Ryken TC, Smith MC, Sneed P, Suh JH, Mehta M, Olson JJ. Radiation therapy of
pathologically confirmed newly diagnosed glioblastoma in adults. J Neurooncol. 2008
Sep;89(3):313-337.
Bukowski RM. What role do combinations of interferon and targeted agents play in the first-line
therapy of metastatic renal cell carcinoma? Clin Genitourin Cancer. 2008 Dec;6(3):s14-s21.
Bukowski RM. Randomized trial of bevacizumab in advanced renal cell carcinoma. Curr Oncol
Rep. 2008 Mar;10(2):99-100.
Bukowski RM. How I treat renal cell carcinoma. J Oncol Pract. 2008 May;4(3):150-152.
Bukowski RM. Renal cell carcinoma: a model system for novel drug development? Clin
Genitourin Cancer. 2008 Mar;6(1):7-8.
Bukowski RM. Optimizing utilization of targeted therapies in genitourinary cancers. Clin
Genitourin Cancer. 2008 Dec;6(3):s6.
Calderon O, Lott DG, Lorenz RR. Radiology quiz case 1. Congenital dermoid cyst. Arch
Otolaryngol Head Neck Surg. 2008 May;134(5):554-557.
Campbell SC, Stephenson AJ. Editorial comment [Is robotic radical cystectomy an appropriate
treatment for bladder cancer? Short-term oncologic and clinical follow-up in 50 consecutive
patients]. Urology. 2008 Sep;72(3):620-621.
Campbell SC. Editorial comment [Renal cell carcinoma in young and old patients-Is there a
difference?]. J Urol. 2008 Oct;180(4):1266.
Campbell SC. The paradigm shift in renal mass biopsy. Clin Adv Hematol Oncol. 2008
Apr;6(4):253-258.
Campbell SC. Editorial comment [Indications for preoperative prostate biopsy in patients
undergoing radical cystoprostatectomy for bladder cancer]. J Urol. 2008 Nov;180(5):1941.
Campbell SC. Editorial comment [Excise, ablate or observe: The small renal mass dilemma-A
meta-analysis and review]. J Urol. 2008 Apr;179(4):1233.
Campbell SC. Editorial comment [Radical nephrectomy for pT1a renal masses may be
associated with decreased overall survival compared with partial nephrectomy]. J Urol. 2008
Feb;179(2):472.
Carlson TP, Kaplan M, Ciezki JP, Elshaikh M, Reddy CA, Ulchaker J, Angermeier K, Chehade N,
Altman A, Klein EA. The role of prophylactic tamsulosin (Flomax) +- dexamethasone in patients
undergoing prostate I125 seed implants for prostate carcinoma: A randomized double-blind study.
Turk Uroloji Dergisi. 2008;34(3):285-290.
Cascon A, Landa I, Lopez-Jimenez E, Diez-Hernandez A, Buchta M, Montero-Conde C, Leskela
S, Leandro-Garcia LJ, Leton R, Rodriguez-Antona C, Eng C, Neumann HPH, Robledo M.
Molecular characterisation of a common SDHB deletion in paraganglioma patients. J Med Genet.
2008 Apr;45(4):233-238.
Chahine LM, Malik B, Davis M. Palliative care needs of patients with neurologic or neurosurgical
conditions. Eur J Neurol. 2008 Dec;15(12):1265-1272.
Chakrabarti A, Sadler AJ, Kar N, Young HA, Silverman RH, Williams BRG. Protein kinase Rdependent regulation of interleukin-10 in response to double-stranded RNA. J Biol Chem. 2008
Sep 12;283(37):25132-25139.
Chao ST, Barnett GH, Vogelbaum MA, Angelov L, Weil RJ, Neyman G, Reuther AM, Suh JH.
Salvage stereotactic radiosurgery effectively treats recurrences from whole-brain radiation
therapy. Cancer. 2008 Oct 15;113(8):2198-2204.
Chappelow AV, Singh AD, Perez VL, Lichtin A, Pohlman B, Macklis R. Bilateral panocular
involvement with mantle-cell lymphoma. J Clin Oncol. 2008 Mar 1;26(7):1167.
Cheema B, Lagman RL, Walsh D, Estfan B, Shaheen P, Davis MP, LeGrand SB. A prospective
study of opioid rotation in pain due to advanced cancer. Journal of Cancer Pain & Symptom
Palliation. 2008 Jan 16;2(3):39-46.
Chen K, Febbraio M, Li W, Silverstein RL. A specific CD36-dependent signaling pathway is
required for platelet activation by oxidized low-density lipoprotein. Circ Res. 2008 Jun
20;102(12):1512-1519.
Cheng L, MacLennan GT, Zhang S, Wang M, Zhou M, Tan PH, Foster S, Lopez-Beltran A,
Montironi R. Evidence for polyclonal origin of multifocal clear cell renal cell carcinoma. Clin
Cancer Res. 2008 Dec 15;14(24):8087-8093.
Cho MY, Kim HS, Eng C, Kim DS, Kang SJ, Eom M, Yi SY, Bronner MP. First report of ovarian
dysgerminoma in Cowden syndrome with germline PTEN mutation and PTEN-related 10q loss of
tumor heterozygosity. Am J Surg Pathol. 2008 Aug;32(8):1258-1264.
Choueiri TK, Bukowski RM, Escudier B. In reply [Efficacy of sunitinib and sorafenib in non-clear
cell renal cell carcinoma: results from expanded access studies]. J Clin Oncol. 2008 Jul
10;26(20):3471.
Choueiri TK, Raghavan D. Chemotherapy for muscle-invasive bladder cancer treated with
definitive radiotherapy: persisting uncertainties. Nat Clin Pract Oncol. 2008 Aug;5(8):444-454.
Choueiri TK, Vaziri SAJ, Jaeger E, Elson P, Wood L, Bhalla IP, Small EJ, Weinberg V, Sein N,
Simko J, Golshayan AR, Sercia L, Zhou M, Waldman FM, Rini BI, Bukowski RM, Ganapathi R.
von Hippel-Lindau gene status and response to vascular endothelial growth factor targeted
therapy for metastatic clear cell renal cell carcinoma. J Urol. 2008 Sep;180(3):860-865.
Choueiri TK, Plantade A, Elson P, Negrier S, Ravaud A, Oudard S, Zhou M, Rini BI, Bukowski
RM, Escudier B. Efficacy of sunitinib and sorafenib in metastatic papillary and chromophobe
renal cell carcinoma. J Clin Oncol. 2008 Jan 1;26(1):127-131.
Choueiri TK, Dreicer R, Paciorek A, Carroll PR, Konety B. A model that predicts the probability of
positive imaging in prostate cancer cases with biochemical failure after initial definitive local
therapy. J Urol. 2008 Mar;179(3):906-910.
Choueiri TK, Baz RC, McFadden CM, Khasawneh M, Karam MA, Kelly M, Hussein MA. An
association between renal cell carcinoma and multiple myeloma: a case series and clinical
implications. BJU Int. 2008 Mar;101(6):712-715.
Chuang FP, Novick AC, Sun GH, Kleeman M, Flechner S, Krishnamurthi V, Modlin C, Shoskes
D, Goldfarb DA. Graft outcomes of living donor renal transplantations in elderly recipients.
Transplant Proc. 2008 Sep;40(7):2299-2302.
Ciezki JP. Editorial comment [Prostate Specific Antigen Working Group guidelines on prostate
specific antigen doubling time]. J Urol. 2008 Jun;179(6):2185.
Cohen PA, Koski GK, Czerniecki BJ, Bunting KD, Fu XY, Wang Z, Zhang WJ, Carter CS, Awad
M, Distel CA, Nagem H, Paustian CC, Johnson TD, Tisdale JF, Shu S. STAT3- and STAT5dependent pathways competitively regulate the pan-differentiation of CD34pos cells into tumorcompetent dendritic cells. Blood. 2008 Sep 1;112(5):1832-1843.
Cohen VML, Sweetenham J, Singh AD. Ocular adnexal lymphoma. What is the evidence for an
infectious aetiology? Br J Ophthalmol. 2008 Apr;92(4):446-448.
Colombo JR Jr, Haber GP, Jelovsek JE, Lane B, Novick AC, Gill IS. Seven years after
laparoscopic radical nephrectomy: oncologic and renal functional outcomes. Urology. 2008
Jun;71(6):1149-1154.
Crowe JP, Patrick RJ, Yetman RJ, Djohan R. Nipple-sparing mastectomy update: one hundred
forty-nine procedures and clinical outcomes. Arch Surg. 2008 Nov;143(11):1106-1110.
da Luz Moreira A, Vogel JD, Kalady MF, Hammel J, Fazio VW. Fever evaluations after colorectal
surgery: identification of risk factors that increase yield and decrease cost. Dis Colon Rectum.
2008 May;51(5):508-513.
Dai X, Nie S, Ke T, Liu J, Wang Q, Liu M. [Two variants in MYOC and CYP1B1 genes in a
Chinese family with primary angle-closure glaucoma] [Chinese]. Zhonghua Yi Xue Yi Chuan Xue
Za Zhi. 2008 Oct;25(5):493-496.
Dai XH, Chen WW, Wang X, Zhu QH, Li C, Li L, Liu MG, Wang QK, Liu JY. A novel genetic
locus for familial febrile seizures and epilepsy on chromosome 3q26.2-q26.33. Hum Genet. 2008
Nov;124(4):423-429.
Daneshvar H, Nelms J, Muhammad O, Jackson H, Tkach J, Davros W, Peterson T, Vogelbaum
MA, Bruchez MP, Toms SA. Imaging characteristics of zinc sulfide shell, cadmium telluride core
quantum dots. Nanomed. 2008 Feb;3(1):21-29.
Das T, Sa G, Paszkiewicz-Kozik E, Hilston C, Molto L, Rayman P, Kudo D, Biswas K, Bukowski
RM, Finke JH, Tannenbaum CS. Renal cell carcinoma tumors induce T cell apoptosis through
receptor-dependent and receptor-independent pathways. J Immunol. 2008 Apr 1;180(7):46874696.
Das T, Sa G, Hilston C, Kudo D, Rayman P, Biswas K, Molto L, Bukowski R, Rini B, Finke JH,
Tannenbaum C. GM1 and tumor necrosis factor-alpha, overexpressed in renal cell carcinoma,
synergize to induce T-cell apoptosis. Cancer Res. 2008 Mar 15;68(6):2014-2023.
Davis M. Opioids and fatal drug poisoning. J Pain Palliat Care Pharmacother. 2008;22(1):30-31.
Davis M. From PC FACS issue 31 - December 15, 2007 survival prediction in the terminally ill:
Commentary. J Palliat Med. 2008;11(3):519-520.
Davis MP. Oral nabilone capsules in the treatment of chemotherapy-induced nausea and
vomiting and pain. Expert Opin Investig Drugs. 2008 Jan;17(1):85-95.
Davis MP, Angst M. In reply [Opioid-induced hyperalgesia may be more frequent than previously
thought]. J Clin Oncol. 2008 Mar 20;26(9):1565.
Davis MP. Cancer constipation: are opioids really the culprit? Support Care Cancer. 2008
May;16(5):427-429.
Davis MP, Angst M. In reply [Opioid-induced pain]. J Clin Oncol. 2008 Jul 10;26(20):3465.
Davis MP, Kirkova J. Lifting symptom burden-how far off the ground are we? Support Care
Cancer. 2008 Jul;16(7):757-761.
de Bono JS, Scher HI, Montgomery RB, Parker C, Miller MC, Tissing H, Doyle GV, Terstappen
LWWM, Pienta KJ, Raghavan D. Circulating tumor cells predict survival benefit from treatment in
metastatic castration-resistant prostate cancer [Erratum in: Clin Cancer Res 2009 Feb
15;15(4):1506]. Clin Cancer Res. 2008 Oct 1;14(19):6302-6309.
de la Taille A, Jones JS, Klein EA. Open to debate. The motion: at least 18 cores are necessary
to make a prostatic biopsy useful. Eur Urol. 2008 Mar;53(3):659-662.
Dean RM, Fry T, Mackall C, Steinberg SM, Hakim F, Fowler D, Odom J, Foley J, Gress R, Bishop
MR. Association of serum interleukin-7 levels with the development of acute graft-versus-host
disease. J Clin Oncol. 2008 Dec 10;26(35):5735-5741.
Deroche T, Walker E, Magi-Galluzzi C, Zhou M. Pathologic characteristics of solitary small renal
masses: can they be predicted by preoperative clinical parameters? Am J Clin Pathol. 2008
Oct;130(4):560-564.
Derweesh IH, Ismail HR, Goldfarb DA, Araki M, Zhou L, Modlin C, Krishnamurthi V, Flechner SM,
Novick AC. Intraoperative placing of drains decreases the incidence of lymphocele and deep
vein thrombosis after renal transplantation. BJU Int. 2008 Jun;101(11):1415-1419.
Desjardins A, Reardon DA, Herndon JE II, Marcello J, Quinn JA, Rich JN, Sathornsumetee S,
Gururangan S, Sampson J, Bailey L, Bigner DD, Friedman AH, Friedman HS, Vredenburgh JJ.
Bevacizumab plus irinotecan in recurrent WHO grade 3 malignant gliomas. Clin Cancer Res.
2008 Nov 1;14(21):7068-7073.
Dhar NB, Klein EA, Reuther AM, Thalmann GN, Madersbacher S, Studer UE. Outcome after
radical cystectomy with limited or extended pelvic lymph node dissection. J Urol. 2008
Mar;179(3):873-878.
Dhar NB, Jones JS, Reuther AM, Dreicer R, Campbell SC, Sanii K, Klein EA. Presentation,
location and overall survival of pelvic recurrence after radical cystectomy for transitional cell
carcinoma of the bladder. BJU Int. 2008 Apr;101(8):969-972.
Diab DL, Faiman C, Siperstein AE, Zhou M, Zimmerman RS. Virilizing adrenal ganglioneuroma
in a woman with subclinical Cushing syndrome. Endocr Pract. 2008 Jul;14(5):584-587.
Diaz P, Xu J, Astruc-Diaz F, Pan HM, Brown DL, Naguib M. Design and synthesis of a novel
series of N-alkyl isatin acylhydrazone derivatives that act as selective cannabinoid receptor 2
agonists for the treatment of neuropathic pain. J Med Chem. 2008 Aug 28;51(16):4932-4947.
Dong B, Silverman RH, Kandel ES. A natural human retrovirus efficiently complements vectors
based on murine leukemia virus. PLoS ONE. 2008;3(9):e3144.
Dong F, Kattan MW, Steyerberg EW, Jones JS, Stephenson AJ, Schroder FH, Klein EA.
Validation of pretreatment nomograms for predicting indolent prostate cancer: efficacy in
contemporary urological practice. J Urol. 2008 Jul;180(1):150-154.
Dong F, Jones JS, Stephenson AJ, Magi-Galluzzi C, Reuther AM, Klein EA. Prostate cancer
volume at biopsy predicts clinically significant upgrading. J Urol. 2008 Mar;179(3):896-900.
Downs-Kelly E, Mendelin JE, Bennett AE, Castilla E, Henricks WH, Schoenfield L, Skacel M,
Yerian L, Rice TW, Rybicki LA, Bronner MP, Goldblum JR. Poor interobserver agreement in the
distinction of high-grade dysplasia and adenocarcinoma in pretreatment Barrett's esophagus
biopsies. Am J Gastroenterol. 2008 Sep;103(9):2333-2340.
Dreicer R. Chemotherapy for the palliation of advanced prostate cancer. J Support Oncol. 2008
Feb;6(2):95-96.
Dreicer R. Current status of cytotoxic chemotherapy in patients with metastatic prostate cancer.
Urol Oncol. 2008 Jul;26(4):426-429.
Dreicer R, Li H, Cooney MM, Wilding G, Roth BJ. Phase 2 trial of pemetrexed disodium and
gemcitabine in advanced urothelial cancer (E4802): a trial of the Eastern Cooperative Oncology
Group. Cancer. 2008 Jun 15;112(12):2671-2675.
Dreicer R. Advanced bladder cancer: So many drugs, so little progress : what's wrong with this
picture? Cancer. 2008 Sep 15;113(6):1275-1277.
Dua HS, Singh AD. The British Journal of Ophthalmology. At a glance. Br J Ophthalmol. 2008
Jul;92(7):869.
Dunbar AJ, Gondek LP, O'Keefe CL, Makishima H, Rataul MS, Szpurka H, Sekeres MA, Wang
XF, McDevitt MA, Maciejewski JP. 250K single nucleotide polymorphism array karyotyping
identifies acquired uniparental disomy and homozygous mutations, including novel missense
substitutions of c-Cbl, in myeloid malignancies. Cancer Res. 2008 Dec 15;68(24):10349-10357.
Eisen T, Oudard S, Szczylik C, Gravis G, Heinzer H, Middleton R, Cihon F, Anderson S, Shah S,
Bukowski R, Escudier B. Sorafenib for older patients with renal cell carcinoma: subset analysis
from a randomized trial. J Natl Cancer Inst. 2008 Oct 15;100(20):1454-1463.
Elkassabany NM, Bhatia J, Deogaonkar A, Barnett GH, Lotto M, Maurtua M, Ebrahim Z, Schubert
A, Ference S, Farag E. Perioperative complications of blood brain barrier disruption under
general anesthesia: a retrospective review. J Neurosurg Anesthesiol. 2008 Jan;20(1):45-48.
Eng C. Microenvironmental protection in diffuse large-B-cell lymphoma. N Engl J Med. 2008 Nov
27;359(22):2379-2381.
Eng C, Assie G, LaFramboise T. Germline genomic homozygosity and cancer risk - Reply.
JAMA. 2008 Jul 9;300(2):170.
Eng C. SDHB--A gene for all tumors? J Natl Cancer Inst. 2008 Sep 3;100(17):1193-1195.
Eng C. Cancer: A ringleader identified. Nature. 2008 Oct 16;455(7215):883-884.
Eng C. From high school dream to genomic medicine reality. Per Med. 2008 Nov;5(6):569-573.
Espinosa I, Lee CH, Kim MK, Rouse BT, Subramanian S, Montgomery K, Varma S, Corless CL,
Heinrich MC, Smith KS, Wang Z, Rubin B, Nielsen TO, Seitz RS, Ross DT, West RB, Cleary ML,
van de Rijn M. A novel monoclonal antibody against DOG1 is a sensitive and specific marker for
gastrointestinal stromal tumors. Am J Surg Pathol. 2008 Feb;32(2):210-218.
Estfan B, Walsh D. The cough from hell: diazepam for intractable cough in a patient with renal
cell carcinoma. J Pain Symptom Manage. 2008 Nov;36(5):553-558.
Evens AM, Sweetenham JW, Horning SJ. Hodgkin lymphoma in older patients: an uncommon
disease in need of study. Oncology (Williston Park). 2008 Nov 15;22(12):1369-1379.
Eyler CE, Foo WC, Lafiura KM, McLendon RE, Hjelmeland AB, Rich JN. Brain cancer stem cells
display preferential sensitivity to akt inhibition. Stem Cells. 2008 Dec;26(12):3027-3036.
Eyler CE, Rich JN. Survival of the fittest: cancer stem cells in therapeutic resistance and
angiogenesis. J Clin Oncol. 2008 Jun 10;26(17):2839-2845.
Fader AN, von Gruenigen V, Gibbons H, Abushahin F, Starks D, Markman M, Belinson J, Rose
P. Improved tolerance of primary chemotherapy with reduced-dose carboplatin and paclitaxel in
elderly ovarian cancer patients. Gynecol Oncol. 2008 Apr;109(1):33-38.
Faiman B, Bilotti E, Mangan PA, Rogers K. Steroid-associated side effects in patients with
multiple myeloma: Consensus statement of the IMF Nurse Leadership Board. Clin J Oncol Nurs.
2008 Jun;12(3 Suppl):53-62.
Falk GW. Obesity and gastroesophageal reflux disease: another piece of the puzzle.
Gastroenterology. 2008 May;134(5):1620-1622.
Falk GW. Preface: GI Clinics of North America [An update on esophageal diseases].
Gastroenterol Clin North Am. 2008 Dec;37(4):xiii-xiv.
Falk GW. Is conventional endoscopic identification of non-erosive reflux disease adequate?
Digestion. 2008 Oct;78 Suppl 1:17-23.
Falk GW. Evaluating the association of Helicobacter pylori to GERD. Gastroenterology &
Hepatology. 2008;4(9):631-632.
Falk GW, Jankowski J. Chemoprevention and Barrett's esophagus: decisions, decisions. Am J
Gastroenterol. 2008 Oct;103(10):2443-2445.
Falk GW. The future of endoscopic treatment of early Barrett neoplasia: The endoscopist's view.
Endoscopy. 2008 Dec;40(12):1041-1047.
Fanning LR, Hegerfeldt Y, Tary-Lehmann M, Lesniewski M, Maciejewski J, Weitzel RP, Kozik M,
Finney M, Lazarus HM, Paul P, Ratajczak MZ, Meyerson HJ, Laughlin MJ. Allogeneic
transplantation of multiple umbilical cord blood units in adults: role of pretransplant-mixed
lymphocyte reaction to predict host-vs-graft rejection. Leukemia. 2008 Sep;22(9):1786-1790.
Feng A, Liu P, Yang T, Wang Y, Chen X, Liu M, Wang Q, Liu J. [Analysis of human hair basic
keratin 6 gene mutation in a Chinese Han family with monilethrix] [Chinese]. Zhonghua Yi Xue Yi
Chuan Xue Za Zhi. 2008 Apr;25(2):141-144.
Feng W, McCabe NP, Mahabeleshwar GH, Somanath PR, Phillips DR, Byzova TV. The
angiogenic response is dictated by {beta}3 integrin on bone marrow-derived cells. J Cell Biol.
2008 Dec 15;183(6):1145-1157.
Finke JH, Rini B, Ireland J, Rayman P, Richmond A, Golshayan A, Wood L, Elson P, Garcia J,
Dreicer R, Bukowski R. Sunitinib reverses type-1 immune suppression and decreases Tregulatory cells in renal cell carcinoma patients. Clin Cancer Res. 2008 Oct 15;14(20):6674-6682.
Fitzgerald DP, Palmieri D, Hua E, Hargrave E, Herring JM, Qian Y, Vega-Valle E, Weil RJ, Stark
AM, Vortmeyer AO, Steeg PS. Reactive glia are recruited by highly proliferative brain metastases
of breast cancer and promote tumor cell colonization. Clin Exp Metastasis. 2008;25(7):799-810.
Flaig TW, Tangen CM, Hussain MHA, Stadler WM, Raghavan D, Crawford ED, Glode LM.
Randomization reveals unexpected acute leukemias in Southwest Oncology Group prostate
cancer trial. J Clin Oncol. 2008 Mar 20;26(9):1532-1536.
Fu EX, Hayden BC, Singh AD. Intraocular tumors. Ultrasound Clin. 2008 Apr;3(2):229-244.
Fu P, van Heeckeren WJ, Wadhwa PD, Bajor DJ, Creger RJ, Xu Z, Cooper BW, Laughlin MJ,
Gerson SL, Koc ON, Lazarus HM. Time-dependent effect of non-Hodgkin's lymphoma grade on
disease-free survival of relapsed/refractory patients treated with high-dose chemotherapy plus
autotransplantation. Contemp Clin Trials. 2008 Mar;29(2):157-164.
Fukuyama R, Niculaita R, Ng KP, Obusez E, Sanchez J, Kalady M, Aung PP, Casey G, Sizemore
N. Mutated in colorectal cancer, a putative tumor suppressor for serrated colorectal cancer,
selectively represses beta-catenin-dependent transcription. Oncogene. 2008 Oct 16;27(46):60446055.
Fuller ML, Sweetenham J, Schoenfield L, Singh AD. Uveal lymphoma: a variant of ocular
adnexal lymphoma. Leuk Lymphoma. 2008 Dec;49(12):2393-2397.
Gabrilove J, Paquette R, Lyons RM, Mushtaq C, Sekeres MA, Tomita D, Dreiling L. Phase 2,
single-arm trial to evaluate the effectiveness of darbepoetin alfa for correcting anaemia in patients
with myelodysplastic syndromes. Br J Haematol. 2008 Aug;142(3):379-393.
Gallina A, Chun FKH, Suardi N, Eastham JA, Perrotte P, Graefen M, Hutterer G, Huland H, Klein
EA, Reuther A, Montorsi F, Briganti A, Shariat SF, Roehrborn CG, de la Taille A, Salomon L,
Karakiewicz PI. Comparison of stage migration patterns between Europe and the USA: an
analysis of 11 350 men treated with radical prostatectomy for prostate cancer. BJU Int. 2008
Jun;101(12):1513-1518.
Garcia JA, Klein EA, Magi-Galluzzi C, Elson P, Triozzi P, Dreicer R. Clinical and biological
effects of neoadjuvant sargramostim and thalidomide in patients with locally advanced prostate
carcinoma. Clin Cancer Res. 2008 May 15;14(10):3052-3059.
Garcia JA, Danielpour D. Mammalian target of rapamycin inhibition as a therapeutic strategy in
the management of urologic malignancies. Mol Cancer Ther. 2008 Jun;7(6):1347-1354.
Garfield DH, Wolter P, Schoffski P, Hercbergs A, Davis P. Documentation of thyroid function in
clinical studies with sunitinib: why does it matter? J Clin Oncol. 2008 Nov 1;26(31):5131-5132.
Garfield DH, Hercbergs A. Fewer dollars, more sense. J Clin Oncol. 2008 Nov 10;26(32):53045305.
Garfield DH, Hercbergs A, Davis P. Management of hypothyroidism after radiotherapy for
nasopharyngeal carcinoma. Med Oncol. 2008;25(4):474-475.
George S, Kasimis BS, Cogswell J, Schwarzenberger P, Shapiro GI, Fidias P, Bukowski RM.
Phase I study of flavopiridol in combination with Paclitaxel and Carboplatin in patients with nonsmall-cell lung cancer. Clin Lung Cancer. 2008 May;9(3):160-165.
George S, Hutson TE, Mekhail T, Wood L, Finke J, Elson P, Dreicer R, Bukowski RM. Phase I
trial of PEG-interferon and recombinant IL-2 in patients with metastatic renal cell carcinoma.
Cancer Chemother Pharmacol. 2008 Jul;62(2):347-354.
George S, Dreicer R, Au JJL, Shen T, Rini BI, Roman S, Cooney MM, Mekhail T, Elson P,
Wientjes GM, Ganapathi R, Bukowski RM. Phase I/II trial of 5-fluorouracil and a noncytotoxic
dose level of suramin in patients with metastatic renal cell carcinoma. Clin Genitourin Cancer.
2008 Sep;6(2):79-85.
Georgitsi M, De Menis E, Cannavo S, Makinen MJ, Tuppurainen K, Pauletto P, Curto L, Weil RJ,
Paschke R, Zielinski G, Wasik A, Lubinski J, Vahteristo P, Karhu A, Aaltonen LA. Aryl
hydrocarbon receptor interacting protein (AIP) gene mutation analysis in children and adolescents
with sporadic pituitary adenomas. Clin Endocrinol (Oxf ). 2008 Oct;69(4):621-627.
Ghosh A, Li W, Febbraio M, Espinola RG, McCrae KR, Cockrell E, Silverstein RL. Platelet CD36
mediates interactions with endothelial cell-derived microparticles and contributes to thrombosis in
mice. J Clin Invest. 2008 May 1;118(5):1934-1943.
Gianduzzo T, Colombo JR Jr, Haber GP, Hafron J, Magi-Galluzzi C, Aron M, Gill IS, Kaouk JH.
Laser robotically assisted nerve-sparing radical prostatectomy: a pilot study of technical feasibility
in the canine model. BJU Int. 2008 Aug 5;102(5):598-602.
Gibson SE, Schade AE, Szpurka H, Bak B, Maciejewski JP, Hsi ED. Phospho-STAT5 expression
pattern with the MPL W515L mutation is similar to that seen in chronic myeloproliferative
disorders with JAK2 V617F. Hum Pathol. 2008 Jul;39(7):1111-1114.
Gibson SE, Zeng WF, Weil RJ, Prayson RA. Aurora B kinase expression in ependymal
neoplasms. Appl Immunohistochem Mol Morphol. 2008 May;16(3):274-278.
Goldfarb DA, Campbell SC. Kidneys from patients with small renal tumours: A novel source of
kidneys for transplantation - Commentary. BJU Int. 2008 Jul;102(2):192-193.
Golshayan AR, Brick AJ, Choueiri TK. Predicting outcome to VEGF-targeted therapy in
metastatic clear-cell renal cell carcinoma: data from recent studies. Future Oncol. 2008
Feb;4(1):85-92.
Gondek LP, Tiu R, O'Keefe CL, Sekeres MA, Theil KS, Maciejewski JP. Chromosomal lesions
and uniparental disomy detected by SNP arrays in MDS, MDS/MPD, and MDS-derived AML.
Blood. 2008 Feb 1;111(3):1534-1542.
Gralow J, Ozols RF, Bajorin DF, Cheson BD, Sandler HM, Winer EP, Bonner J, Demetri GD,
Curran W,Jr, Ganz PA, Kramer BS, Kris MG, Markman M, Mayer RJ, Raghavan D, Ramsey S,
Reaman GH, Sawaya R, Schuchter LM, Sweetenham JW, Vahdat LT, Davidson NE, Schilsky RL,
Lichter AS. Clinical cancer advances 2007: major research advances in cancer treatment,
prevention, and screening--a report from the american society of clinical oncology. J Clin Oncol.
2008 Jan 10;26(2):313-325.
Grant LW, Anderson C, Macklis RM, Singh AD. Low dose irradiation for diffuse choroidal
hemangioma. Ophthalmic Genet. 2008 Dec;29(4):186-188.
Gratzinger D, Zhao S, Tibshirani RJ, Hsi ED, Hans CP, Pohlman B, Bast M, Avigdor A, Schiby G,
Nagler A, Byrne GE Jr, Lossos IS, Natkunam Y. Prognostic significance of VEGF, VEGF
receptors, and microvessel density in diffuse large B cell lymphoma treated with anthracyclinebased chemotherapy. Lab Invest. 2008 Jan;88(1):38-47.
Grossman SA, Carson KA, Phuphanich S, Batchelor T, Peereboom D, Nabors LB, Lesser G,
Hausheer F, Supko JG. Phase I and pharmacokinetic study of karenitecin in patients with
recurrent malignant gliomas. Neuro Oncol. 2008 Aug;10(4):608-616.
Grossman SA, Olson J, Batchelor T, Peereboom D, Lesser G, Desideri S, Ye X, Hammour T,
Supko JG. Effect of phenytoin on celecoxib pharmacokinetics in patients with glioblastoma.
Neuro Oncol. 2008 Apr;10(2):190-198.
Grothey E, Gibson T, Sartor O, Bukowski R. Highlights from: The 2008 meeting of the American
Society of Clinical Oncology; May 30-June 3, 2008; Chicago, IL. Clin Genitourin Cancer. 2008
Sep;6(2):65-72.
Guo S, Chao ST, Reuther AM, Barnett GH, Suh JH. Review of the treatment of trigeminal
neuralgia with gamma knife radiosurgery. Stereotact Funct Neurosurg. 2008;86(3):135-146.
Gupta D, Crosby ME, Almasan A, Macklis RM. Regulation of CD20 expression by radiationinduced changes in intracellular redox status. Free Radic Biol Med. 2008 Feb 15;44(4):614-623.
Gupta S, Young D, Maitra RK, Gupta A, Popovic ZB, Yong SL, Mahajan A, Wang Q, Sen S.
Prevention of cardiac hypertrophy and heart failure by silencing of NF-kappaB. J Mol Biol. 2008
Jan 18;375(3):637-649.
Gururangan S, Krauser J, Watral MA, Driscoll T, Larrier N, Reardon DA, Rich JN, Quinn JA,
Vredenburgh JJ, Desjardins A, McLendon RE, Fuchs H, Kurtzberg J, Friedman HS. Efficacy of
high-dose chemotherapy or standard salvage therapy in patients with recurrent medulloblastoma.
Neuro Oncol. 2008 Oct;10(5):745-751.
Haas RH, Parikh S, Falk MJ, Saneto RP, Wolf NI, Darin N, Wong LJ, Cohen BH, Naviaux RK.
The in-depth evaluation of suspected mitochondrial disease. Mol Genet Metab. 2008
May;94(1):16-37.
Haddad A, Maciejewski JP, Kalaycio M. Clinical significance of cytogenetics in myelodysplastic
syndromes. Lab Med. 2008 Jun;39(6):367-371.
Haddad AS, Subbiah V, Lichtin AE, Theil KS, Maciejewski JP. Hypocupremia and bone marrow
failure. Haematologica. 2008 Jan;93(1):e1-e5.
Haferlach C, Bacher U, Tiu R, Maciejewski JP, List A. Myelodysplastic syndromes with del(5q):
indications and strategies for cytogenetic testing. Cancer Genet Cytogenet. 2008 Dec;187(2):101111.
Hamadani M, Awan FT, Copelan EA. Hematopoietic stem cell transplantation in adults with acute
myeloid leukemia. Biol Blood Marrow Transplant. 2008 May;14(5):556-567.
Hammer C, Fanning A, Crowe J. Overview of breast cancer staging and surgical treatment
options. Cleve Clin J Med. 2008 Mar;75 Suppl 1:S10-S16.
Hansel DE, Rini BI. Molecular genetics of hereditary renal cancer: new genes and diagnostic and
therapeutic opportunities. Expert Rev Anticancer Ther. 2008 Jun;8(6):895-905.
Hansel DE, Swain E, Dreicer R, Tubbs RR. HER2 overexpression and amplification in urothelial
carcinoma of the bladder Is associated with MYC coamplification in a subset of cases. Am J Clin
Pathol. 2008 Aug;130(2):274-281.
Hari P, Carreras J, Zhang MJ, Gale RP, Bolwell BJ, Bredeson CN, Burns LJ, Cairo MS, Freytes
CO, Goldstein SC, Hale GA, Inwards DJ, Lemaistre CF, Maharaj D, Marks DI, Schouten HC,
Slavin S, Vose JM, Lazarus HM, van Besien K. Allogeneic transplants in follicular lymphoma:
higher risk of disease progression after reduced-intensity compared to myeloablative
conditioning. Biol Blood Marrow Transplant. 2008 Feb;14(2):236-245.
Hartsell WF, Desilvio M, Bruner DW, Scarantino C, Ivker R, Roach M III, Suh J, Demas WF,
Movsas B, Petersen IA, Konski AA. Can physicians accurately predict survival time in patients
with metastatic cancer? Analysis of RTOG 97-14. J Palliat Med. 2008 Jun;11(5):723-728.
Hauser K, Walsh D. Visual analogue scales and assessment of quality of life in cancer. J
Support Oncol. 2008 Jul;6(6):277-282.
Hauser K, Walsh D, Rybicki LA, Davis MP, Seyidova-Khoshknabi D. Fatigue in advanced
cancer: a prospective study. Am J Hosp Palliat Care. 2008 Oct;25(5):372-378.
Hayden BC, Kelley L, Singh AD. Ophthalmic ultrasonography: Theoretic and practical
considerations. Ultrasound Clin. 2008 Apr;3(2):179-183.
Heinrich MC, Owzar K, Corless CL, Hollis D, Borden EC, Fletcher CDM, Ryan CW, von Mehren
M, Blanke CD, Rankin C, Benjamin RS, Bramwell VH, Demetri GD, Bertagnolli MM, Fletcher JA.
Correlation of kinase genotype and clinical outcome in the North American Intergroup Phase III
Trial of imatinib mesylate for treatment of advanced gastrointestinal stromal tumor: CALGB
150105 Study by Cancer and Leukemia Group B and Southwest Oncology Group. J Clin Oncol.
2008 Nov 20;26(33):5360-5367.
Heng DYC, Bukowski RM. Anti-angiogenic targets in the treatment of advanced renal cell
carcinoma. Curr Cancer Drug Targets. 2008 Dec;8(8):676-682.
Herts BR, Schneider E, Poggio ED, Obuchowski NA, Baker ME. Identifying outpatients with renal
insufficiency before contrast-enhanced CT by using estimated glomerular filtration rates versus
serum creatinine levels. Radiology. 2008 Jul;248(1):106-113.
Housri N, Weil RJ, Shalowitz DI, Koniaris LG. Should informed consent for cancer treatment
include a discussion about hospital outcome disparities? PLoS Med. 2008 Oct 21;5(10):e214.
Hu Y, Li L, Seidelmann SB, Timur AA, Shen PH, Driscoll DJ, Wang QK. Identification of
association of common AGGF1 variants with susceptibility for Klippel-Trenaunay syndrome using
the structure association program. Ann Hum Genet. 2008 Sep;72(Pt 5):636-643.
Hussein MA, Vrionis FD, Allison R, Berenson J, Berven S, Erdem E, Giralt S, Jagannath S, Kyle
RA, LeGrand S, Pflugmacher R, Raje N, Rajkumar SV, Randall L, Roodman D, Siegel D, Vescio
R, Zonder J, Durie BGM. The role of vertebral augmentation in multiple myeloma: International
Myeloma Working Group Consensus Statement [Erratum in: Leukemia. 2008 Aug;22(8):1649].
Leukemia. 2008 Aug;22(8):1479-1484.
Iczkowski KA, Butler SL, Shanks JH, Hossain D, Schall A, Meiers I, Zhou M, Torkko KC, Kim SJ,
MacLennan GT. Trials of new germ cell immunohistochemical stains in 93 extragonadal and
metastatic germ cell tumors. Hum Pathol. 2008 Feb;39(2):275-281.
Jankowska AM, Gondek LP, Szpurka H, Nearman ZP, Tiu RV, Maciejewski JP. Base excision
repair dysfunction in a subgroup of patients with myelodysplastic syndrome. Leukemia. 2008
Mar;22(3):551-558.
Ji J, Eng C, Hemminki K. Familial risk for soft tissue tumors: a nation-wide epidemiological study
from Sweden. J Cancer Res Clin Oncol. 2008 May;134(5):617-624.
Jin X, Zhao Y, Richardson A, Moore L, Williams PS, Zborowski M, Chalmers JJ. Differences in
magnetically induced motion of diamagnetic, paramagnetic, and superparamagnetic
microparticles detected by cell tracking velocimetry. Analyst. 2008 Dec;133(12):1767-1775.
Jing Y, Mal N, Williams PS, Mayorga M, Penn MS, Chalmers JJ, Zborowski M. Quantitative
intracellular magnetic nanoparticle uptake measured by live cell magnetophoresis. FASEB J.
2008 Dec;22(12):4239-4247.
Johnson MD, Sade B, Milano MT, Lee JH, Toms SA. New prospects for management and
treatment of inoperable and recurrent skull base meningiomas. J Neurooncol. 2008
Jan;86(1):109-122.
Jois-Bilowich P, Michota F, Bartholomew JR, Glauser J, Diercks D, Weber J, Fonarow GC,
Emerman CL, Peacock WF IV. Venous thromboembolism prophylaxis in hospitalized heart
failure patients. J Card Fail. 2008 Mar;14(2):127-132.
Jokinen CH, Dadras SS, Goldblum JR, van de Rijn M, West RB, Rubin BP. Diagnostic
implications of podoplanin expression in peripheral nerve sheath neoplasms. Am J Clin Pathol.
2008 Jun;129(6):886-893.
Jonasch E, Stadler WM, Bukowski RM, Hayes TG, Varadhachary A, Malik R, Figlin RA, Srinivas
S. Phase 2 trial of talactoferrin in previously treated patients with metastatic renal cell carcinoma.
Cancer. 2008 Jul 1;113(1):72-77.
Jones GA, Kayanja M, Milks R, Lieberman I. Biomechanical characteristics of hybrid hook-screw
constructs in short-segment thoracic fixation. Spine. 2008 Jan 15;33(2):173-177.
Jones JS, Klein EA. Editorial comment [What percentage of patients with newly diagnosed
â„¢
carcinoma of the prostate are candidates for surveillance? An analysis of the CaPSURE
database]. J Urol. 2008 Oct;180(4):1334-1335.
Jones JS, Klein E. Four no more: The 'PSA cutoff era' is over. Cleve Clin J Med. 2008
Jan;75(1):30-32.
Juliano JJ, Cody RL, Suh JH. Metastatic adrenocortical oncocytoma: A case report. Urol Oncol.
2008 Mar-Apr;26(2):198-201.
Kalady MF, Mantyh CR, Petrofski J, Ludwig KA. Routine contrast imaging of low pelvic
anastomosis prior to closure of defunctioning ileostomy: is it necessary? J Gastrointest Surg.
2008 Jul;12(7):1227-1231.
Kalady MF, Fazio VW. Academic surgery: does it have a future? ANZ J Surg. 2008
May;78(5):337-338.
Kalaycio M, Advani A, Pohlman B, Sekeres M, Tripp B, Rybicki L, Sobecks R. Timed sequential
induction chemotherapy and risk-adapted postremission therapy for acute myelogenous
leukemia. Am J Hematol. 2008 Nov;83(11):831-834.
Kalaycio M. Clinical experience with bendamustine: a new treatment for patients with chronic
lymphocytic leukemia. Clinical Leukemia. 2008 Nov;2(4):223-229.
Kalmadi S, Raghavan D. Evolving perspectives of the role of novel agents in androgenindependent prostate cancer. Indian J Urol. 2008 Jul;24(3):303-308.
Kalmadi SR, Rankin C, Kraut MJ, Jacobs AD, Petrylak DP, Adelstein DJ, Keohan ML, Taub RN,
Borden EC. Gemcitabine and cisplatin in unresectable malignant mesothelioma of the pleura: A
phase II study of the Southwest Oncology Group (SWOG 9810). Lung Cancer. 2008
May;60(2):259-263.
Kang TY, Jin T, Elinzano H, Peereboom D. Irinotecan and bevacizumab in progressive primary
brain tumors, an evaluation of efficacy and safety. J Neurooncol. 2008 Aug;89(1):113-118.
Kanowitz SJ, Batra PS, Citardi MJ. Topical budesonide via mucosal atomization device in
refractory postoperative chronic rhinosinusitis. Otolaryngol Head Neck Surg. 2008 Jul;139(1):131136.
Kanowitz SJ, Batra PS, Citardi MJ. Comprehensive management of failed frontal sinus
obliteration. Am J Rhinol. 2008 May;22(3):263-270.
Kapural L, Ng A, Dalton J, Mascha E, Kapural M, de la Garza M, Mekhail N. Intervertebral disc
biacuplasty for the treatment of lumbar discogenic pain: results of a six-month follow-up. Pain
Med. 2008 Jan-Feb;9(1):60-67.
Kapural L, Mekhail N, Hicks D, Kapural M, Sloan S, Moghal N, Ross J, Petrinec D. Histological
changes and temperature distribution studies of a novel bipolar radiofrequency heating system in
degenerated and nondegenerated human cadaver lumbar discs. Pain Med. 2008 JanFeb;9(1):68-75.
Kapural L, Nageeb F, Kapural M, Cata JP, Narouze S, Mekhail N. Cooled radiofrequency system
for the treatment of chronic pain from sacroiliitis: the first case-series. Pain Pract. 2008
Sep;8(5):348-354.
Karakiewicz PI, Bhojani N, Capitanio U, Reuther AM, Suardi N, Jeldres C, Pharand D, Peloquin
F, Perrotte P, Shariat SF, Klein EA. External validation of the updated Partin tables in a cohort of
North American men. J Urol. 2008 Sep;180(3):898-902.
Karl S, David M, Moore L, Grimberg BT, Michon P, Mueller I, Zborowski M, Zimmerman PA.
Enhanced detection of gametocytes by magnetic deposition microscopy predicts higher potential
for Plasmodium falciparum transmission. Malar J. 2008;7:66.
Karnak I, Woo LL, Shah SN, Sirajuddin A, Kay R, Ross JH. Prenatally detected ureteropelvic
junction obstruction: clinical features and associated urologic abnormalities. Pediatr Surg Int.
2008 Apr;24(4):395-402.
Kauser F, LeGrand SB. Theophylline for unexplained dyspnea in palliative medicine: a case
report. J Palliat Med. 2008 May-Jun;11(3):510-513.
Kavanagh B, O'Brien S, Lee D, Hou Y, Weinberg V, Rini B, Allison JP, Small EJ, Fong L. CTLA4
blockade expands FoxP3+ regulatory and activated effector CD4+ T cells in a dose-dependent
fashion. Blood. 2008 Aug 15;112(4):1175-1183.
Keeler R, Singh AD, Dua HS. Anatomical eye model. Br J Ophthalmol. 2008 Sep;92(9):1179.
Keeler R, Singh A, Dua H. Focimeter. Br J Ophthalmol. 2008 May;92(5):593.
Kefer JC, Campbell SC. Current status of prostate-sparing cystectomy. Urol Oncol. 2008
Sep;26(5):486-493.
Khariwala SS, Dan O, Lorenz RR, Klimczak A, Siemionow M, Strome M. Donor bone marrow in
laryngeal transplantation: results of a rat study. Am J Otolaryngol. 2008 Jul;29(4):242-249.
Khatri RG, Navaratne K, Weil RJ. The role of a single nucleotide polymorphism of MDM2 in
glioblastoma multiforme. J Neurosurg. 2008 Nov;109(5):842-848.
Khoshknabi DS, Davis MP, Ranganathan VK, Siemionow V, Walsh D, Kirkova J, Yue GH.
Combining objective and subjective outcomes in cancer-related fatigue: illustrations from a single
case report. J Palliat Med. 2008 Jul;11(6):829-833.
Kim S, Kim N, Dong B, Boren D, Lee SA, Das Gupta J, Gaughan C, Klein EA, Lee C, Silverman
RH, Chow SA. Integration site preference of xenotropic murine leukemia virus-related virus, a
new human retrovirus associated with prostate cancer. J Virol. 2008 Oct;82(20):9964-9977.
Kim SH, Weil RJ, Chao ST, Toms SA, Angelov L, Vogelbaum MA, Suh JH, Barnett GH.
Stereotactic radiosurgical treatment of brain metastases in older patients. Cancer. 2008 Aug
15;113(4):834-840.
Kim SH, Chao ST, Toms SA, Vogelbaum MA, Barnett GH, Suh JH, Weil RJ. Stereotactic
radiosurgical treatment of parenchymal brain metastases from prostate adenocarcinoma. Surg
Neurol. 2008 Jun;69(6):641-646.
Klein E. Prostate cancer. Urol Oncol. 2008 Sep;26(5):494.
Klein E. Expert commentary: Dr. Klein [A 43-year-old African American man with low-risk
prostate cancer]. Curr Urol Rep. 2008 Nov;9(6):438.
Klein EA, Stephenson AJ, Raghavan D, Dreicer R. Systems pathology and predicting outcome
after radical prostatectomy. J Clin Oncol. 2008 Aug 20;26(24):3916-3917.
Klein EA, Bianco FJ, Serio AM, Eastham JA, Kattan MW, Pontes JE, Vickers AJ, Scardino PT.
Surgeon experience is strongly associated with biochemical recurrence after radical
prostatectomy for all preoperative risk categories. J Urol. 2008 Jun;179(6):2212-2216; discussion
2216-2217.
Klein EA. Balancing act. Urology. 2008 Dec;72(6):1189.
Klein EA, Silverman R. Inflammation, infection, and prostate cancer. Curr Opin Urol. 2008
May;18(3):315-319.
Klein EA. Letter from the editor. Urology. 2008 Jan;71(1):1-2.
Klein EA. Editorial comment [High anterior release of the levator fascia improves sexual function
following open radical retropubic prostatectomy]. J Urol. 2008 Dec;180(6):2564.
Klein EA, Kattan M, Stephenson A, Vickers A. How many lymphadenectomies does it take to
cure one patient? Eur Urol. 2008 Jan;53(1):13-15.
Koski GK, Cohen PA, Roses RE, Xu S, Czerniecki BJ. Reengineering dendritic cell-based anticancer vaccines. Immunol Rev. 2008 Apr;222:256-276.
Kovoor TA, Bahl D, Singh AD, Ufret-Vincenty R. Bilateral isolated choroidal melanocytosis. Br J
Ophthalmol. 2008 Jul;92(7):892, 1008.
Kruser TJ, Chao ST, Elson P, Barnett GH, Vogelbaum MA, Angelov L, Weil RJ, Pelley R, Suh JH.
Multidisciplinary management of colorectal brain metastases: a retrospective study. Cancer. 2008
Jul 1;113(1):158-165.
Kumagai K, Vasanji A, Drazba JA, Butler RS, Muschler GF. Circulating cells with osteogenic
potential are physiologically mobilized into the fracture healing site in the parabiotic mice model. J
Orthop Res. 2008 Feb;26(2):165-175.
Kupelian PA, Willoughby TR, Reddy CA, Klein EA, Mahadevan A. Impact of image guidance on
outcomes after external beam radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol
Phys. 2008 Mar 15;70(4):1146-1150.
Kupelian PA, Ciezki J, Reddy CA, Klein EA, Mahadevan A. Effect of increasing radiation doses
on local and distant failures in patients with localized prostate cancer. Int J Radiat Oncol Biol
Phys. 2008 May 1;71(1):16-22.
Kuter DJ, Bussel JB, Lyons RM, Pullarkat V, Gernsheimer TB, Senecal FM, Aledort LM, George
JN, Kessler CM, Sanz MA, Liebman HA, Slovick FT, de Wolf JTM, Bourgeois E, Guthrie TH Jr,
Newland A, Wasser JS, Hamburg SI, Grande C, Lefrere F, Lichtin AE, Tarantino MD, Terebelo
HR, Viallard JF, Cuevas FJ, Go RS, Henry DH, Redner RL, Rice L, Schipperus MR, Guo DM,
Nichol JL. Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a
double-blind randomised controlled trial. Lancet. 2008 Feb 2;371(9610):395-403.
Lacouture ME, Wu S, Robert C, Atkins MB, Kong HH, Guitart J, Garbe C, Hauschild A, Puzanov
I, Alexandrescu DT, Anderson RT, Wood L, Dutcher JP. Evolving strategies for the management
of hand-foot skin reaction associated with the multitargeted kinase inhibitors sorafenib and
sunitinib. Oncologist. 2008 Sep;13(9):1001-1011.
Lagman R, Walsh D, Heintz J, LeGrand SB, Davis MP. A day in the life: a case series of acute
care palliative medicine--the cleveland model. Am J Hosp Palliat Care. 2008 Feb;25(1):24-32.
Laheru D, Croghan G, Bukowski R, Rudek M, Messersmith W, Erlichman C, Pelley R, Jimeno A,
Donehower R, Boni J, Abbas R, Martins P, Zacharchuk C, Hidalgo M. A phase I study of EKB569 in combination with capecitabine in patients with advanced colorectal cancer. Clin Cancer
Res. 2008 Sep 1;14(17):5602-5609.
Lai DW, Loughran TPJr, Maciejewski JP, Sasu S, Song SX, Epling-Burnette PK, Paquette RL.
Acquired amegakaryocytic thrombocytopenia and pure red cell aplasia associated with an occult
large granular lymphocyte leukemia. Leuk Res. 2008 May;32(5):823-827.
Lane BR, Samplaski MK, Herts BR, Zhou M, Novick AC, Campbell SC. Renal mass biopsy--a
renaissance? J Urol. 2008 Jan;179(1):20-27.
Lane BR, Novick AC, Babineau D, Fergany AF, Kaouk JH, Gill IS. Comparison of laparoscopic
and open partial nephrectomy for tumor in a solitary kidney. J Urol. 2008 Mar;179(3):847-851;
discussion 852.
Lane BR, Stephenson AJ, Magi-Galluzzi C, Lakin MM, Klein EA. Low testosterone and risk of
biochemical recurrence and poorly differentiated prostate cancer at radical prostatectomy.
Urology. 2008 Dec;72(6):1240-1245.
Lane BR, Campbell SC, Remer EM, Fergany AF, Williams SB, Novick AC, Weight CJ, MagiGalluzzi C, Zhou M. Adult cystic nephroma and mixed epithelial and stromal tumor of the kidney:
clinical, radiographic, and pathologic characteristics. Urology. 2008 Jun;71(6):1142-1148.
Lane BR, Aydin H, Danforth TL, Zhou M, Remer EM, Novick AC, Campbell SC. Clinical
correlates of renal angiomyolipoma subtypes in 209 patients: classic, fat poor, tuberous sclerosis
associated and epithelioid. J Urol. 2008 Sep;180(3):836-843.
Lane BR, Zippe CD, Abouassaly R, Schoenfield L, Magi-Galluzzi C, Jones JS. Saturation
technique does not decrease cancer detection during followup after initial prostate biopsy. J Urol.
2008 May;179(5):1746-1750.
Lane Z, Hansel DE, Epstein JI. Immunohistochemical expression of prostatic antigens in
adenocarcinoma and villous adenoma of the urinary bladder. Am J Surg Pathol. 2008
Sep;32(9):1322-1326.
Lara A, Khatri SB, Wang Z, Comhair SAA, Xu W, Dweik RA, Bodine M, Levison BS, Hammel J,
Bleecker E, Busse W, Calhoun WJ, Castro M, Chung KF, Curran-Everett D, Gaston B, Israel E,
Jarjour N, Moore W, Peters SP, Teague WG, Wenzel S, Hazen SL, Erzurum SC. Alterations of
the arginine metabolome in asthma. Am J Respir Crit Care Med. 2008 Oct 1;178(7):673-681.
Larson BT, Magi-Galluzzi C, Casey G, Plummer SJ, Silverman R, Klein EA. Pathological
aggressiveness of prostatic carcinomas related to RNASEL R462Q allelic variants. J Urol. 2008
Apr;179(4):1344-1348.
Lauer ME, Erzurum SC, Mukhopadhyay D, Vasanji A, Drazba J, Wang A, Fulop C, Hascall VC.
Differentiated murine airway epithelial cells synthesize a leukocyte-adhesive hyaluronan matrix in
response to endoplasmic reticulum stress. J Biol Chem. 2008 Sep 19;283(38):26283-26296.
Lazarus HM, Carreras J, Boudreau C, Loberiza FR Jr, Armitage JO, Bolwell BJ, Freytes CO,
Gale RP, Gibson J, Hale GA, Inwards DJ, Lemaistre CF, Maharaj D, Marks DI, Miller AM,
Pavlovsky S, Schouten HC, van Besien K, Vose JM, Bitran JD, Khouri IF, McCarthy PL, Yu H,
Rowlings P, Serna DS, Horowitz MM, Rizzo JD. Influence of age and histology on outcome in
adult non-Hodgkin lymphoma patients undergoing autologous hematopoietic cell transplantation
(HCT): a report from the Center For International Blood & Marrow Transplant Research
(CIBMTR). Biol Blood Marrow Transplant. 2008 Dec;14(12):1323-1333.
Lee BJ, Jeng BH, Singh AD. OCT and ultrasound biomicroscopic findings in iris arteriovenous
malformation. Ophthalmic Surg Lasers Imaging. 2008 Sep;39(5):426-428.
Lee SJ, Kukreja M, Wang T, Giralt SA, Szer J, Arora M, Woolfrey AE, Cervantes F, Champlin RE,
Gale RP, Halter J, Keating A, Marks DI, McCarthy PL, Olavarria E, Stadtmauer EA, Abecasis M,
Gupta V, Khoury HJ, George B, Hale GA, Liesveld JL, Rizzieri DA, Antin JH, Bolwell BJ, Carabasi
MH, Copelan E, Ilhan O, Litzow MR, Schouten HC, Zander AR, Horowitz MM, Maziarz RT.
Impact of prior imatinib mesylate on the outcome of hematopoietic cell transplantation for chronic
myeloid leukemia. Blood. 2008 Oct 15;112(8):3500-3507.
Lee WT, Tubbs RR, Teker AM, Scharpf J, Strome M, Wood B, Lorenz RR, Hunt J. Use of in situ
hybridization to detect human papillomavirus in head and neck squamous cell carcinoma patients
without a history of alcohol or tobacco use. Arch Pathol Lab Med. 2008 Oct;132(10):1653-1656.
Lee WT, Tamai H, Cohen P, Teker AM, Shu S. Immunotherapy of established murine squamous
cell carcinoma using fused dendritic-tumor cell hybrids. Arch Otolaryngol Head Neck Surg. 2008
Jun;134(6):608-613.
LeGrand SB, Leskuski D, Zama I. Narrative review: Furosemide for hypercalcemia: an unproven
yet common practice. Ann Intern Med. 2008 Aug 19;149(4):259-263.
Lenz G, Wright G, Dave SS, Xiao W, Powell J, Zhao H, Xu W, Tan B, Goldschmidt N, Iqbal J,
Vose J, Bast M, Fu K, Weisenburger DD, Greiner TC, Armitage JO, Kyle A, May L, Gascoyne
RD, Connors JM, Troen G, Holte H, Kvaloy S, Dierickx D, Verhoef G, Delabie J, Smeland EB,
Jares P, Martinez A, Lopez-Guillermo A, Montserrat E, Campo E, Braziel RM, Miller TP, Rimsza
LM, Cook JR, Pohlman B, Sweetenham J, Tubbs RR, Fisher RI, Hartmann E, Rosenwald A, Ott
G, Muller-Hermelink HK, Wrench D, Lister TA, Jaffe ES, Wilson WH, Chan WC, Staudt LM.
Stromal gene signatures in large-B-cell lymphomas. N Engl J Med. 2008 Nov 27;359(22):23132323.
Lesniewski ML, Haviernik P, Weitzel RP, Kadereit S, Kozik MM, Fanning LR, Yang YC,
Hegerfeldt Y, Finney MR, Ratajczak MZ, Greco N, Paul P, Maciejewski J, Laughlin MJ.
Regulation of IL-2 expression by transcription factor BACH2 in umbilical cord blood CD4(+) T
cells [Erratum in: Leukemia. 2008 Nov;22(12):2293-2294]. Leukemia. 2008 Dec;22(12):22012207.
Li H, Li C, Lu Q, Su T, Ke T, Li DWC, Yuan M, Liu J, Ren X, Zhang Z, Zeng S, Wang QK, Liu M.
Cataract mutation P20S of alphaB-crystallin impairs chaperone activity of alphaA-crystallin and
induces apoptosis of human lens epithelial cells. Biochim Biophys Acta. 2008 May;1782(5):303309.
Li J, Yin C, Okamoto H, Balgley BM, Lee CS, Yuan K, Ikejiri B, Glasker S, Vortmeyer AO, Oldfield
EH, Weil RJ, Zhuang Z. Identification of a novel proliferation-related protein, WHSC1 4a, in
human gliomas. Neuro Oncol. 2008 Feb;10(1):45-51.
Li W, Silverstein RL. Biological surgery: synergetic angiogenic therapy using coadministration of
two progenitor cell populations. Circ Res. 2008 Sep 26;103(7):684-686.
Lichtin AE. How safe are erythropoiesis-stimulating agents? Cleve Clin J Med. 2008
May;75(5):359-360.
Lieberman I, Siemionow KB. Vertebral augmentation for spinal metastases. Spinal Column. 2008
Spring;5-7.
Lin HY, Tang HY, Keating T, Wu YH, Shih A, Hammond D, Sun M, Hercbergs A, Davis FB, Davis
PJ. Resveratrol is pro-apoptotic and thyroid hormone is anti-apoptotic in glioma cells: both
actions are integrin and ERK mediated. Carcinogenesis. 2008 Jan;29(1):62-69.
Liu JY, Dai X, Sheng J, Cui X, Wang X, Jiang X, Tu X, Tang Z, Bai Y, Liu M, Wang QK.
Identification and functional characterization of a novel splicing mutation in RP gene PRPF31.
Biochem Biophys Res Commun. 2008 Mar 7;367(2):420-426.
Liu P, Zhang S, Yao Q, Liu X, Wang X, Huang C, Huang X, Wang P, Yuan M, Liu JY, Wang QK,
Liu M. Identification of a genetic locus for autosomal dominant disseminated superficial actinic
porokeratosis on chromosome 1p31.3-p31.1. Hum Genet. 2008 Jun;123(5):507-513.
Liu P, Yang Q, Wang X, Feng A, Yang T, Yang R, Wang P, Yuang M, Liu M, Liu JY, Wang QK.
Identification of a genetic locus for ichthyosis vulgaris on chromosome 10q22.3-q24.2. J Invest
Dermatol. 2008 Jun;128(6):1418-1422.
Liu Q, Oberti C, Zhang X, Ke T, Zhang T, Scheinman M, Hu D, Wang QK. [A novel mutation of
F189L in CASQ2 in families with catecholaminergic polymorphic ventricular tachycardia]
[Chinese]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2008 Jun;25(3):334-337.
Lo SS, Fakiris AJ, Abdulrahman R, Henderson MA, Chang EL, Suh JH, Timmerman RD. Role of
stereotactic radiosurgery and fractionated stereotactic radiotherapy in pediatric brain tumors.
Expert Rev Neurother. 2008 Jan;8(1):121-132.
Lobo GP, Waite KA, Planchon SM, Romigh T, Houghton JA, Eng C. ATP modulates PTEN
subcellular localization in multiple cancer cell lines. Hum Mol Genet. 2008 Sep 15;17(18):28772885.
Lorenz RR, Esclamado RM, Teker AM, Strome M, Scharpf J, Hicks D, Milstein C, Lee WT. Ansa
cervicalis-to-recurrent laryngeal nerve anastomosis for unilateral vocal fold paralysis: experience
of a single institution. Ann Otol Rhinol Laryngol. 2008 Jan;117(1):40-45.
Luong A, Batra PS, Fakhri S, Citardi MJ. Balloon catheter dilatation for frontal sinus ostium
stenosis in the office setting. Am J Rhinol. 2008 Nov-Dec;22(6):621-624.
Lystad LD, Hayden BC, Singh AD. Optic nerve disorders. Ultrasound Clin. 2008 Apr;3(2):257266.
Maciejewski JP, Mufti GJ. Whole genome scanning as a cytogenetic tool in hematologic
malignancies. Blood. 2008 Aug 15;112(4):965-974.
Mackley HB, Adelstein JS, Reddy CA, Adelstein DJ, Rice TW, Saxton JP, Videtic GMM. Choice
of radiotherapy planning modality influences toxicity in the treatment of locally advanced
esophageal cancer. J Gastrointest Cancer. 2008;39(1-4):130-137.
Macklis RM, Hagenbeek A. Frontline postchemotherapy consolidation with 90Y-Zevalin RIT:
finally an ideal role for RIT in lymphoma management? Am J Hematol Oncol. 2008 May;7(5):190192.
Mahabeleshwar GH, Byzova TV. Vascular integrin signaling. Methods Enzymol. 2008;443:199226.
Mahabeleshwar GH, Chen J, Feng W, Somanath PR, Razorenova OV, Byzova TV. Integrin
affinity modulation in angiogenesis. Cell Cycle. 2008 Feb;7(3):335-347.
Mahindra A, Bolwell B, Sobecks R, Rybicki L, Pohlman B, Dean R, Andresen S, Sweetenham J,
Kalaycio M, Copelan E. Elevated ferritin is associated with relapse after autologous
hematopoietic stem cell transplantation for lymphoma. Biol Blood Marrow Transplant. 2008
Nov;14(11):1239-1244.
Malinin N, Byzova T. CD40/TRAF6 switch in neointimal hyperplasia. Blood. 2008 May
1;111(9):4424.
Malinowski KT, Noel C, Roy M, Willoughby T, Djemi T, Jani S, Solberg T, Liu D, Levine L, Parikh
PJ. Efficient use of continuous, real-time prostate localization. Phys Med Biol. 2008 Sep
21;53(18):4959-4970.
Malogolowkin M, Cotton CA, Green DM, Breslow NE, Perlman E, Miser J, Ritchey ML, Thomas
PRM, Grundy PE, D'Angio GJ, Beckwith JB, Shamberger RC, Haase GM, Donaldson M,
Weetman R, Coppes MJ, Shearer P, Coccia P, Kletzel M, Macklis R, Tomlinson G, Huff V,
Newbury R, Weeks D. Treatment of Wilms tumor relapsing after initial treatment with vincristine,
actinomycin D, and doxorubicin. A report from the National Wilms Tumor Study Group. Pediatr
Blood Cancer. 2008 Feb;50(2):236-241.
Mamounas EP, Budd GT, Miller KD. Incorporating the oncotype DX breast cancer assay into
community pratice: An expert Q&A and case study sampling. Clin Adv Hematol Oncol. 2008
Feb;6(2 Suppl 3):1-8.
Mao H, Thakur CS, Chattopadhyay S, Silverman RH, Gudkov A, Banerjee AK. Inhibition of
human parainfluenza virus type 3 infection by novel small molecules. Antiviral Res. 2008
Feb;77(2):83-94.
Marchi N, Mazzone P, Fazio V, Mekhail T, Masaryk T, Janigro D. ProApolipoprotein A1: a serum
marker of brain metastases in lung cancer patients. Cancer. 2008 Mar 15;112(6):1313-1324.
Marko NF, Toms SA, Barnett GH, Weil R. Genomic expression patterns distinguish long-term
from short-term glioblastoma survivors: a preliminary feasibility study. Genomics. 2008
May;91(5):395-406.
Marks DI, Perez WS, He W, Zhang MJ, Bishop MR, Bolwell BJ, Bredeson CN, Copelan EA, Gale
RP, Gupta V, Hale GA, Isola LM, Jakubowski AA, Keating A, Klumpp TR, Lazarus HM, Liesveld
JL, Maziarz RT, McCarthy PL, Sabloff M, Schiller G, Sierra J, Tallman MS, Waller EK, Wiernik
PH, Weisdorf DJ. Unrelated donor transplants in adults with Philadelphia-negative acute
lymphoblastic leukemia in first complete remission. Blood. 2008 Jul 15;112(2):426-434.
Mazumder S, Plesca D, Almasan A. Caspase-3 activation is a critical determinant of genotoxic
stress-induced apoptosis. Methods Mol Biol. 2008;414:13-21.
McCabe NP, Madajka M, Vasanji A, Byzova TV. Intraosseous injection of RM1 murine prostate
cancer cells promotes rapid osteolysis and periosteal bone deposition. Clin Exp Metastasis.
2008;25(5):581-590.
McIver Z, Serio B, Dunbar A, O'Keefe CL, Powers J, Wlodarski M, Jin T, Sobecks R, Bolwell B,
Maciejewski JP. Double-negative regulatory T cells induce allotolerance when expanded after
allogeneic haematopoietic stem cell transplantation. Br J Haematol. 2008 Apr;141(2):170-178.
Mehta A, Lichtin AE, Vigg A, Parambil JG. Platelet larceny: spurious hypoxaemia due to extreme
thrombocytosis. Eur Respir J. 2008 Feb;31(2):469-472.
Milos IN, Frank-Raue K, Wohllk N, Maia AL, Pusiol E, Patocs A, Robledo M, Biarnes J, Barontini
M, Links TP, de Groot JW, Dvorakova S, Peczkowska M, Rybicki LA, Sullivan M, Raue F, Zosin I,
Eng C, Neumann HPH. Age-related neoplastic risk profiles and penetrance estimations in
multiple endocrine neoplasia type 2A caused by germ line RET Cys634Trp (TGC>TGG)
mutation. Endocr Relat Cancer. 2008 Dec;15(4):1035-1041.
Mirzoyan M, Muslimani A, Setrakian S, Swedeh M, Daw HA. Primary pleuropulmonary synovial
sarcoma. Clin Lung Cancer. 2008 Sep;9(5):257-261.
Moeller M. Genomics in breast cancer care. Women's Health Care. 2008 Sep;7(9):19-24.
Mroz TE, Joyce MJ, Steinmetz MP, Lieberman IH, Wang JC. Musculoskeletal allograft risks and
recalls in the United States. J Am Acad Orthop Surg. 2008 Oct;16(10):559-565.
Mroz TE, Yamashita T, Davros WJ, Lieberman IH. Radiation exposure to the surgeon and the
patient during kyphoplasty. J Spinal Disord Tech. 2008 Apr;21(2):96-100.
Muslimani A, Francis NS, Gopalakrishna KV, Daw HA. Disseminated cryptococcosis in a patient
with idiopathic CD4+ T-lymphocytopenia. Clin Adv Hematol Oncol. 2008 Jun;6(6):446-452.
Muslimani AA, Farag HL, Francis S, Spiro TP, Chaudhry AA, Chan VC, Taylor HC, Daw HA. The
utility of 18-F-fluorodeoxyglucose positron emission tomography in evaluation of bone marrow
involvement by non-Hodgkin lymphoma. Am J Clin Oncol. 2008 Oct;31(5):409-412.
Muslimani AA, Spiro TP, Daw HA, Chan VC, Bambakidis P. Neurolymphomatosis: The challenge
of diagnosis and treatment. Community Oncology. 2008 Jun;5(6):339-341.
Natkunam Y, Farinha P, Hsi ED, Hans CP, Tibshirani R, Sehn LH, Connors JM, Gratzinger D,
Rosado M, Zhao S, Pohlman B, Wongchaowart N, Bast M, Avigdor A, Schiby G, Nagler A, Byrne
GE, Levy R, Gascoyne RD, Lossos IS. LMO2 protein expression predicts survival in patients with
diffuse large B-cell lymphoma treated with anthracycline-based chemotherapy with and without
rituximab. J Clin Oncol. 2008 Jan 20;26(3):447-454.
Neznanov N, Kondratova A, Chumakov KM, Neznanova L, Kondratov R, Banerjee AK, Gudkov
AV. Quercetinase pirin makes poliovirus replication resistant to flavonoid quercetin. DNA Cell
Biol. 2008 Apr;27(4):191-198.
Neznanov N, Dragunsky EM, Chumakov KM, Neznanova L, Wek RC, Gudkov AV, Banerjee AK.
Different effect of proteasome inhibition on vesicular stomatitis virus and poliovirus replication.
PLoS ONE. 2008;3(4):e1887.
Nguyen CT, Campbell SC, Novick AC. Choice of operation for clinically localized renal tumor.
Urol Clin North Am. 2008 Nov;35(4):645-655.
Nguyen CT, Lane BR, Kaouk JH, Hegarty N, Gill IS, Novick AC, Campbell SC. Surgical salvage
of renal cell carcinoma recurrence after thermal ablative therapy. J Urol. 2008 Jul;180(1):104-109.
Nguyen CT, Campbell SC. Salvage of local recurrence after primary thermal ablation for small
renal masses. Expert Rev Anticancer Ther. 2008 Dec;8(12):1899-1905.
Ni Y, Zbuk KM, Sadler T, Patocs A, Lobo G, Edelman E, Platzer P, Orloff MS, Waite KA, Eng C.
Germline mutations and variants in the succinate dehydrogenase genes in Cowden and Cowdenlike syndromes. Am J Hum Genet. 2008 Aug;83(2):261-268.
Nonaka D, Chiriboga L, Rubin BP. Differential expression of S100 protein subtypes in malignant
melanoma, and benign and malignant peripheral nerve sheath tumors. J Cutan Pathol. 2008
Nov;35(11):1014-1019.
Nonaka D, Chiriboga L, Rubin BP. Sox10: a pan-schwannian and melanocytic marker. Am J
Surg Pathol. 2008 Sep;32(9):1291-1298.
Nonevski IT, Downs-Kelly E, Falk GW. Eosinophilic esophagitis: an increasingly recognized
cause of dysphagia, food impaction, and refractory heartburn. Cleve Clin J Med. 2008
Sep;75(9):623-633.
O'Keefe S. Does the use of cell phones cause brain tumors? Clin J Oncol Nurs. 2008
Aug;12(4):671-672.
Ogino T, Banerjee AK. Formation of guanosine(5')tetraphospho(5')adenosine cap structure by an
unconventional mRNA capping enzyme of vesicular stomatitis virus. J Virol. 2008
Aug;82(15):7729-7734.
Orloff MS, Eng C. Genetic and phenotypic heterogeneity in the PTEN hamartoma tumour
syndrome. Oncogene. 2008 Sep 18;27(41):5387-5397.
Osinbowale O, Bartholomew JR. Rectus sheath hematoma. Vasc Med. 2008 Nov;13(4):275-279.
Osunkoya AO, Hansel DE, Sun X, Netto GJ, Epstein JI. Aberrant diffuse expression of p63 in
adenocarcinoma of the prostate on needle biopsy and radical prostatectomy: report of 21 cases.
Am J Surg Pathol. 2008 Mar;32(3):461-467.
Osunkoya AO, Hansel DE, Parwani AV, Ali TZ, Tamas EF, Untawale VG, Kahane H, Epstein JI.
The Symphony protocol for H&E staining of prostatic adenocarcinoma on needle biopsy: a
multicentre analysis of 120 cases. Pathology. 2008 Aug;40(5):450-456.
Otri AM, Singh AD, Dua HS. Cover illustration. Abu Bakr Razi. Br J Ophthalmol. 2008
Oct;92(10):1324.
Palumbo A, Rajkumar SV, Dimopoulos MA, Richardson PG, San Miguel J, Barlogie B,
Harousseau J, Zonder JA, Cavo M, Zangari M, Attal M, Belch A, Knop S, Joshua D, Sezer O,
Ludwig H, Vesole D, Blade J, Kyle R, Westin J, Weber D, Bringhen S, Niesvizky R, Waage A, von
Lilienfeld-Toal M, Lonial S, Morgan GJ, Orlowski RZ, Shimizu K, Anderson KC, Boccadoro M,
Durie BG, Sonneveld P, Hussein MA. Prevention of thalidomide- and lenalidomide-associated
thrombosis in myeloma. Leukemia. 2008 Feb;22(2):414-423.
Parikh S, Cohen BH, Gupta A, Lachhwani DK, Wyllie E, Kotagal P. Metabolic testing in the
pediatric epilepsy unit. Pediatr Neurol. 2008 Mar;38(3):191-195.
Pasini B, McWhinney SR, Bei T, Matyakhina L, Stergiopoulos S, Muchow M, Boikos SA,
Ferrando B, Pacak K, Assie G, Baudin E, Chompret A, Ellison JW, Briere JJ, Rustin P, GimenezRoqueplo AP, Eng C, Carney JA, Stratakis CA. Clinical and molecular genetics of patients with
the Carney-Stratakis syndrome and germline mutations of the genes coding for the succinate
dehydrogenase subunits SDHB, SDHC, and SDHD. Eur J Hum Genet. 2008 Jan;16(1):79-88.
Pateder DB, Brems J, Lieberman I, Bell GR, McLain RF. Masquerade: nonspinal
musculoskeletal disorders that mimic spinal conditions. Cleve Clin J Med. 2008 Jan;75(1):50-56.
Patocs A, Platzer P, Eng C. The authors reply [Breast-cancer stromal cells with TP53 mutations].
N Engl J Med. 2008 Apr 10;358(15):1636.
Patterson TE, Kumagai K, Griffith L, Muschler GF. Cellular strategies for enhancement of
fracture repair. J Bone Joint Surg Am. 2008 Feb;90 Suppl 1:111-119.
Peczkowska M, Erlic Z, Hoffmann MM, Furmanek M, Cwikla J, Kubaszek A, Prejbisz A,
Szutkowski Z, Kawecki A, Chojnowski K, Lewczuk A, Litwin M, Szyfter W, Walter MA, Sullivan M,
Eng C, Januszewicz A, Neumann HP. Impact of screening kindreds for SDHD p.Cys11X as a
common mutation associated with paraganglioma syndrome type 1. J Clin Endocrinol Metab.
2008 Dec;93(12):4818-4825.
Peczkowska M, Cascon A, Prejbisz A, Kubaszek A, Cwikla BJ, Furmanek M, Erlic Z, Eng C,
Januszewicz A, Neumann HPH. Extra-adrenal and adrenal pheochromocytomas associated with
a germline SDHC mutation. Nat Clin Pract Endocrinol Metab. 2008 Feb;4(2):111-115.
Pennell NA, Daniels GH, Haddad RI, Ross DS, Evans T, Wirth LJ, Fidias PH, Temel JS,
Gurubhagavatula S, Heist RS, Clark JR, Lynch TJ. A phase II study of gefitinib in patients with
advanced thyroid cancer. Thyroid. 2008 Mar;18(3):317-323.
Peyre CG, Hagen JA, DeMeester SR, Altorki NK, Ancona E, Griffin SM, Holscher A, Lerut T, Law
S, Rice TW, Ruol A, van Lanschot JJB, Wong J, DeMeester TR. The number of lymph nodes
removed predicts survival in esophageal cancer: an international study on the impact of extent of
surgical resection. Ann Surg. 2008 Oct;248(4):549-556.
Peyre CG, Hagen JA, DeMeester SR, van Lanschot JJB, Holscher A, Law S, Ruol A, Ancona E,
Griffin SM, Altorki NK, Rice TW, Wong J, Lerut T, DeMeester TR. Predicting systemic disease in
patients with esophageal cancer after esophagectomy: a multinational study on the significance
of the number of involved lymph nodes. Ann Surg. 2008 Dec;248(6):979-985.
Pezzolesi MG, Platzer P, Waite KA, Eng C. Differential expression of PTEN-targeting MicroRNAs
miR-19a and miR-21 in Cowden syndrome. Am J Hum Genet. 2008 May;82(5):1141-1149.
Pineyro MM, Makdissi A, Faiman C, Prayson RA, Reddy SK, Mayberg MC, Weil RJ, Hamrahian
AH. Poor correlation of serum alpha-subunit concentration and magnetic resonance imaging
following pituitary surgery in patients with nonfunctional pituitary macroadenomas. Endocr Pract.
2008 May;14(4):452-457.
Planaguma A, Kazani S, Marigowda G, Haworth O, Mariani TJ, Israel E, Bleecker ER, CurranEverett D, Erzurum SC, Calhoun WJ, Castro M, Chung KF, Gaston B, Jarjour NN, Busse WW,
Wenzel SE, Levy BD. Airway lipoxin A4 generation and lipoxin A4 receptor expression are
decreased in severe asthma. Am J Respir Crit Care Med. 2008 Sep 15;178(6):574-582.
Planchon SM, Waite KA, Eng C. The nuclear affairs of PTEN. J Cell Sci. 2008 Feb 1;121(Pt
3):249-253.
Plesca D, Mazumder S, Almasan A. DNA damage response and apoptosis. Methods Enzymol.
2008;446:107-122.
Plesca D, Mazumder S, Gama V, Matsuyama S, Almasan A. A C-terminal fragment of Cyclin E,
generated by caspase-mediated cleavage, is degraded in the absence of a recognizable
phosphodegron. J Biol Chem. 2008 Nov 7;283(45):30796-30803.
Plon SE, Pirics ML, Nuchtern J, Hicks J, Russell H, Agrawal S, Zbuk K, Eng C, Hegde M, Chin
ELH. Multiple tumors in a child with germ-line mutations in TP53 and PTEN. N Engl J Med. 2008
Jul 31;359(5):537-539.
Purow BW, Sundaresan TK, Burdick MJ, Kefas BA, Comeau LD, Hawkinson MP, Su Q, Kotliarov
Y, Lee J, Zhang W, Fine HA. Notch-1 regulates transcription of the epidermal growth factor
receptor through p53. Carcinogenesis. 2008 May;29(5):918-925.
Qian Y, Zakov ZN, Schoenfield L, Singh AD. Iris melanoma arising in iris nevus in oculo(dermal)
melanocytosis. Surv Ophthalmol. 2008 Jul;53(4):411-415.
Quintini C, Hirose K, Hashimoto K, Diago T, Aucejo F, Eghtesad B, Vogt D, Pierce G, Baker M,
Kelly D, Miller CM. "Splenic artery steal syndrome" is a misnomer: The cause is portal
hyperperfusion, not arterial siphon. Liver Transpl. 2008 Mar;14(3):374-379.
Raghavan D. Prostate cancer: too much dogma, not enough data. Cleve Clin J Med. 2008
Jan;75(1):33-34.
Raghavan D, Klein EA. Prostate cancer: moving forward by reinventing the wheel...but this time
it is round. J Clin Oncol. 2008 Oct 1;26(28):4535-4536.
Rajkumar SV, Rosinol L, Hussein M, Catalano J, Jedrzejczak W, Lucy L, Olesnyckyj M, Yu Z,
Knight R, Zeldis JB, Blade J. Multicenter, randomized, double-blind, placebo-controlled study of
thalidomide plus dexamethasone compared with dexamethasone as initial therapy for newly
diagnosed multiple myeloma. J Clin Oncol. 2008 May 1;26(13):2171-2177.
Reardon DA, Desjardins A, Rich JN, Vredenburgh JJ. The emerging role of anti-angiogenic
therapy for malignant glioma. Curr Treat Options Oncol. 2008 Feb;9(1):1-22.
Reardon DA, Zalutsky MR, Akabani G, Coleman RE, Friedman AH, Herndon JE II, McLendon
RE, Pegram CN, Quinn JA, Rich JN, Vredenburgh JJ, Desjardins A, Guruangan S, Boulton S,
Raynor RH, Dowell JM, Wong TZ, Zhao XG, Friedman HS, Bigner DD. A pilot study: 131Iantitenascin monoclonal antibody 81c6 to deliver a 44-Gy resection cavity boost. Neuro Oncol.
2008 Apr;10(2):182-189.
Reardon DA, Desjardins A, Vredenburgh JJ, Sathornsumetee S, Rich JN, Quinn JA, Lagattuta
TF, Egorin MJ, Gururangan S, McLendon R, Herndon JE II, Friedman AH, Salvado AJ, Friedman
HS. Safety and pharmacokinetics of dose-intensive imatinib mesylate plus temozolomide: phase
1 trial in adults with malignant glioma. Neuro Oncol. 2008 Jun;10(3):330-340.
Rezash V. Can a macrobiotic diet cure cancer? Clin J Oncol Nurs. 2008 Oct;12(5):807-808.
Rice TW, Blackstone EH. Reply to Sersar. Chylothorax revisited and reassessed. Eur J
Cardiothorac Surg. 2008 Jun;33(6):1159-1160.
Rice TW, Blackstone EH. Surgical management of gastroesophageal reflux disease.
Gastroenterol Clin North Am. 2008 Dec;37(4):901-919.
Rich JN, Eyler CE. Cancer stem cells in brain tumor biology. Cold Spring Harb Symp Quant Biol.
2008;73:411-420.
Richardson DL, Seamon LG, Gong MC, Chapman DM, Cohn DE. Panniculectomy concurrent
with anterior pelvic exenteration for recurrent cervical cancer. Gynecol Oncol. 2008
Feb;108(2):449-451.
Rigelsky CM, Jennings C, Lehtonen R, Minai OA, Eng C, Aldred MA. BMPR2 mutation in a
patient with pulmonary arterial hypertension and suspected hereditary hemorrhagic
telangiectasia. Am J Med Genet A. 2008 Oct 1;146A(19):2551-2556.
Rini BI, Michaelson MD, Rosenberg JE, Bukowski RM, Sosman JA, Stadler WM, Hutson TE,
Margolin K, Harmon CS, DePrimo SE, Kim ST, Chen I, George DJ. Antitumor activity and
biomarker analysis of sunitinib in patients with bevacizumab-refractory metastatic renal cell
carcinoma. J Clin Oncol. 2008 Aug 1;26(22):3743-3748.
Rini BI. Editorial comment [Risk score and metastasectomy independently impact prognosis of
patients with recurrent renal cell carcinoma]. J Urol. 2008 Sep;180(3):878.
Rini BI. Lapatinib therapy for patients with advanced renal cell carcinoma. Nat Clin Pract Oncol.
2008 Nov;5(11):626-627.
Rini BI. AMG 386 plus sorafenib in metastatic renal cell carcinoma. Community Oncology.
2008;5(11 Suppl A):1-4.
Rini BI, Flaherty K. Clinical effect and future considerations for molecularly-targeted therapy in
renal cell carcinoma. Urol Oncol. 2008 Sep;26(5):543-549.
Rini BI, Bukowski RM. Targeted therapy for metastatic renal cell carcinoma: a home run or a
work in progress? Oncology (Williston Park). 2008 Apr 15;22(4):388-396.
Rini BI. Is sorafenib plus interferon alpha 2b safe and effective in patients with renal cell
carcinoma? Nat Clin Pract Urol. 2008 Mar;5(3):132-133.
Rini BI. Update on the use of mTOR inhibitors in renal cell carcinoma. Clin Adv Hematol Oncol.
2008 Oct;6(10):722-724.
Rini BI, Shook S. Is Guillain Barre syndrome likely in this patient? Oncology (Williston Park).
2008 Jan;22(1):70-71.
Rini BI, Halabi S, Rosenberg JE, Stadler WM, Vaena DA, Ou SS, Archer L, Atkins JN, Picus J,
Czaykowski P, Dutcher J, Small EJ. Bevacizumab plus interferon alfa compared with interferon
alfa monotherapy in patients with metastatic renal cell carcinoma: CALGB 90206. J Clin Oncol.
2008 Nov 20;26(33):5422-5428.
Rini BI, Rathmell WK, Godley P. Renal cell carcinoma. Curr Opin Oncol. 2008 May;20(3):300306.
Rini BI. Temsirolimus, an inhibitor of Mammalian target of rapamycin. Clin Cancer Res. 2008 Mar
1;14(5):1286-1290.
Rini BI. Quantifying hypertension in patients with cancer treated with sorafenib. Lancet Oncol.
2008 Feb;9(2):86-87.
Rini BI, Choueiri TK, Elson P, Khasawneh MK, Cotta C, Unnithan J, Wood L, Mekhail T, Garcia J,
Dreicer R, Bukowski RM. Sunitinib-induced macrocytosis in patients with metastatic renal cell
carcinoma. Cancer. 2008 Sep 15;113(6):1309-1314.
Rizzo JD, Somerfield MR, Hagerty KL, Seidenfeld J, Bohlius J, Bennett CL, Cella DF, Djulbegovic
B, Goode MJ, Jakubowski AA, Rarick MU, Regan DH, Lichtin AE. Use of epoetin and
darbepoetin in patients with cancer: 2007 American Society of Hematology/American Society of
Clinical Oncology clinical practice guideline update. Blood. 2008 Jan 1;111(1):25-41.
Rizzo JD, Somerfield MR, Hagerty KL, Seidenfeld J, Bohlius J, Bennett CL, Cella DF, Djulbegovic
B, Goode MJ, Jakubowski AA, Miller CB, Rarick MU, Regan DH, Lichtin AE. In reply
[Erythropoiesis-stimulating agents in cancer]. J Clin Oncol. 2008;26(18):3098-3100.
Rizzo JD, Somerfield MR, Hagerty KL, Seidenfeld J, Bohlius J, Bennett CL, Cella DF, Djulbegovic
B, Goode MJ, Jakubowski AA, Rarick MU, Regan DH, Lichtin AE. Use of epoetin and
darbepoetin in patients with cancer: 2007 American Society of Hematology/American Society of
Clinical Oncology clinical practice guideline update. J Clin Oncol. 2008 Jan 1;26(1):132-149.
Rockwood EJ, Sharma S, Hayden BC, Singh AD. Glaucoma. Ultrasound Clin. 2008
Apr;3(2):207-215.
Rodriguez CP, Baz R, Jawde RA, Rybicki LA, Kalaycio ME, Advani A, Sobecks R, Sekeres MA.
Impact of socioeconomic status and distance from treatment center on survival in patients
receiving remission induction therapy for newly diagnosed acute myeloid leukemia. Leuk Res.
2008 Mar;32(3):413-420.
Rodriguez CP, Adelstein DJ, Rybicki LA, Saxton JP, Lorenz RR, Wood BG, Strome M,
Esclamado RM, Lavertu P, Carroll MA. Clinical predictors of larynx preservation after multiagent
concurrent chemoradiotherapy. Head Neck. 2008 Dec;30(12):1535-1542.
Roma A, Varsegi M, Magi-Galluzzi C, Ulbright T, Zhou M. The distinction of bronchogenic cyst
from metastatic testicular teratoma: a light microscopic and immunohistochemical study. Am J
Clin Pathol. 2008 Aug;130(2):265-273.
Ruby CE, Montler R, Zheng R, Shu S, Weinberg AD. IL-12 is required for anti-OX40-mediated
CD4 T cell survival. J Immunol. 2008 Feb 15;180(4):2140-2148.
Sade B, Lee JH. High incidence of optic canal involvement in clinoidal meningiomas: rationale for
aggressive skull base approach. Acta Neurochir (Wien). 2008 Nov;150(11):1127-1132.
Said TM, Agarwal A, Zborowski M, Grunewald S, Glander HJ, Paasch U. Utility of magnetic cell
separation as a molecular sperm preparation technique. J Androl. 2008 Mar-Apr;29(2):134-142.
Saif MW, Hashmi S, Zelterman D, Almhanna K, Kim R. Capecitabine vs continuous infusion 5FU in neoadjuvant treatment of rectal cancer. A retrospective review. Int J Colorectal Dis. 2008
Feb;23(2):139-145.
Sanchez JA, Vogel JD, Kalady MF, Bronner MP, Skacel M, Church JM. Identifying Lynch
syndrome: we are all responsible. Dis Colon Rectum. 2008 Dec;51(12):1750-1756.
Sanda MG, Dunn RL, Michalski J, Sandler HM, Northouse L, Hembroff L, Lin X, Greenfield TK,
Litwin MS, Saigal CS, Mahadevan A, Klein E, Kibel A, Pisters LL, Kuban D, Kaplan I, Wood D,
Ciezki J, Shah N, Wei JT. Quality of life and satisfaction with outcome among prostate-cancer
survivors. N Engl J Med. 2008 Mar 20;358(12):1250-1261.
Sandhu SK, Sekeres MA. Myelodysplastic syndromes: more prevalent than we know. Geriatrics.
2008 Nov;63(11):10-17.
Sarquis MS, Silveira LG, Pimenta FJ, Dias EP, Teh BT, Friedman E, Gomez RS, Tavares GC,
Eng C, De Marco L. Familial hyperparathyroidism: surgical outcome after 30 years of follow-up in
three families with germline HRPT2 mutations. Surgery. 2008 May;143(5):630-640.
Sartor AO, Tangen CM, Hussain MHA, Eisenberger MA, Parab M, Fontana JA, Chapman RA,
Mills GM, Raghavan D, Crawford ED. Antiandrogen withdrawal in castrate-refractory prostate
cancer: a Southwest Oncology Group trial (SWOG 9426). Cancer. 2008 Jun 1;112(11):23932400.
Sathornsumetee S, Rich JN. Designer therapies for glioblastoma multiforme. Ann N Y Acad Sci.
2008 Oct;1142:108-132.
Sathornsumetee S, Cao Y, Marcello JE, Herndon JE II, McLendon RE, Desjardins A, Friedman
HS, Dewhirst MW, Vredenburgh JJ, Rich JN. Tumor angiogenic and hypoxic profiles predict
radiographic response and survival in malignant astrocytoma patients treated with bevacizumab
and irinotecan. J Clin Oncol. 2008 Jan 10;26(2):271-278.
Saunthararajah Y, Molokie R, Saraf S, Sidhwani S, Gowhari M, Vara S, Lavelle D, DeSimone J.
Clinical effectiveness of decitabine in severe sickle cell disease. Br J Haematol. 2008
Apr;141(1):126-129.
Sautter NB, Citardi MJ, Perry J, Batra PS. Paranasal sinus mucoceles with skull-base and/or
orbital erosion: Is the endoscopic approach sufficient? Otolaryngol Head Neck Surg. 2008
Oct;139(4):570-574.
Sautter NB, Batra PS, Citardi MJ. Endoscopic management of sphenoid sinus cerebrospinal fluid
leaks. Ann Otol Rhinol Laryngol. 2008 Jan;117(1):32-39.
Schade AE, Schieven GL, Townsend R, Jankowska AM, Susulic V, Zhang R, Szpurka H,
Maciejewski JP. Dasatinib, a small-molecule protein tyrosine kinase inhibitor, inhibits T-cell
activation and proliferation. Blood. 2008 Feb 1;111(3):1366-1377.
Scher HI, Halabi S, Tannock IF, Morris M, Sternberg CN, Carducci MA, Eisenberger MA, Higano
C, Bubley GJ, Dreicer R, Petrylak DP, Kantoff P, Basch E, Kelly WK, Figg WD, Small EJ, Beer
TM, Wilding G, Martin A, Hussain M. In reply [Trial design for metastatic castration-resistant
prostate cancer]. J Clin Oncol. 2008;26(21):3648-3649.
Scher HI, Halabi S, Tannock I, Morris M, Sternberg CN, Carducci MA, Eisenberger MA, Higano
C, Bubley GJ, Dreicer R, Petrylak D, Kantoff P, Basch E, Kelly WK, Figg WD, Small EJ, Beer TM,
Wilding G, Martin A, Hussain M. Design and end points of clinical trials for patients with
progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate
Cancer Clinical Trials Working Group. J Clin Oncol. 2008 Mar 1;26(7):1148-1159.
Schlenk RF, Pasquini MC, Perez WS, Zhang MJ, Krauter J, Antin JH, Bashey A, Bolwell BJ,
Buchner T, Cahn JY, Cairo MS, Copelan EA, Cutler CS, Dohner H, Gale RP, Ilhan O, Lazarus
HM, Liesveld JL, Litzow MR, Marks DI, Maziarz RT, McCarthy PL, Nimer SD, Sierra J, Tallman
MS, Weisdorf DJ, Horowitz MM, Ganser A. HLA-identical sibling allogeneic transplants versus
chemotherapy in acute myelogenous leukemia with t(8;21) in first complete remission:
collaborative study between the German AML Intergroup and CIBMTR. Biol Blood Marrow
Transplant. 2008 Feb;14(2):187-196.
Seidelmann SB, Li L, Shen GQ, Topol EJ, Wang QK. Identification of a novel locus for
triglyceride on chromosome 1p31-32 in families with premature CAD and MI. J Lipid Res. 2008
May;49(5):1034-1038.
Sekeres MA, Schoonen WM, Kantarjian H, List A, Fryzek J, Paquette R, Maciejewski JP.
Characteristics of US patients with myelodysplastic syndromes: results of six cross-sectional
physician surveys. J Natl Cancer Inst. 2008 Nov 5;100(21):1542-1551.
Sekeres MA, List AF. Active treatment strategies improving outcomes in patients with
myelodysplastic syndromes with the deletion 5q abnormality. Clinical Leukemia. 2008
Feb;2(1):28-33.
Sekeres MA, Maciejewski JP, Giagounidis AA, Wride K, Knight R, Raza A, List AF. Relationship
of treatment-related cytopenias and response to lenalidomide in patients with lower-risk
myelodysplastic syndromes. J Clin Oncol. 2008 Dec 20;26(36):5943-5949.
Sekeres MA. Treatment of older adults with acute myeloid leukemia: state of the art and current
perspectives. Haematologica. 2008 Dec;93(12):1769-1772.
Sengupta S, Michener CM, Escobar P, Belinson J, Ganapathi R. Ovarian cancer immunoreactive antigen domain containing 1 (OCIAD1), a key player in ovarian cancer cell adhesion.
Gynecol Oncol. 2008 May;109(2):226-233.
Serhal D, Weil RJ, Hamrahian AH. Evaluation and management of pituitary incidentalomas.
Cleve Clin J Med. 2008 Nov;75(11):793-801.
Shaiova L, Berger A, Blinderman CD, Bruera E, Davis MP, Derby S, Inturrisi C, Kalman J, Mehta
D, Pappagallo M, Perlov E. Consensus guideline on parenteral methadone use in pain and
palliative care. Palliat Support Care. 2008 Jun;6(2):165-176.
Sharma N, O'Hara J, Novick AC, Lieber M, Remer EM, Herts BR. Correlation between loss of
renal function and loss of renal volume after partial nephrectomy for tumor in a solitary kidney. J
Urol. 2008 Apr;179(4):1284-1288.
Sharma N, Neumann D, Macklis R. The impact of functional imaging on radiation medicine.
Radiat Oncol. 2008 Sep 15;3:25.
Sharma S, Lasheen W, Walsh D. Paraneoplastic refractory hypercalcemia due to advanced
metastatic esthesioneuroblastoma. Rhinology. 2008 Jun;46(2):153-155.
Shedden K, Taylor JMG, Enkemann SA, Tsao MS, Yeatman TJ, Gerald WL, Eschrich S, Jurisica
I, Giordano TJ, Misek DE, Chang AC, Zhu CQ, Strumpf D, Hanash S, Shepherd FA, Ding K,
Seymour L, Naoki K, Pennell N, Weir B, Verhaak R, Ladd-Acosta C, Golub T, Gruidl M, Sharma
A, Szoke J, Zakowski M, Rusch V, Kris M, Viale A, Motoi N, Travis W, Conley B, Seshan VE,
Meyerson M, Kuick R, Dobbin KK, Lively T, Jacobson JW, Beer DG. Gene expression-based
survival prediction in lung adenocarcinoma: a multi-site, blinded validation study. Nat Med. 2008
Aug;14(8):822-827.
Shen GQ, Li L, Rao S, Abdullah KG, Ban JM, Lee BS, Park JE, Wang QK. Four SNPs on
chromosome 9p21 in a South Korean population implicate a genetic locus that confers high
cross-race risk for development of coronary artery disease. Arterioscler Thromb Vasc Biol. 2008
Feb;28(2):360-365.
Singh A, Burke CA, Larive B, Sastri SV. Do gender disparities persist in gastroenterology after
10 years of practice? Am J Gastroenterol. 2008 Jul;103(7):1589-1595.
Singh AD, Schachat AP, Diener-West M, Reynolds SM. Small choroidal melanoma.
Ophthalmology. 2008 Dec;115(12):2319.
Singh AD, Triozzi PL. Endoresection for choroidal melanoma: palliative or curative intent? Br J
Ophthalmol. 2008 Aug;92(8):1015-1016.
Singh AD, Hayden BC, Pavlin CJ. Preface [Ophthalmic ultrasound]. Ultrasound Clin. 2008
Apr;3(2):xi.
Singh AD, Kivela T, Seregard S, Robertson D, Bena JF. Primary transpupillary thermotherapy of
"small" choroidal melanoma: is it safe? Br J Ophthalmol. 2008 Jun;92(6):727-728.
Smedira HJ, Patrick RJ, Rybicki LA, Crowe JP. Integrating medical breast specialists into the
traditional breast center practice model: a review of 11 years of experience. Arch Intern Med.
2008 Oct 13;168(18):2042-2045.
Smith AK, Hansel DE, Jones JS. Role of cystitis cystica et glandularis and intestinal metaplasia
in development of bladder carcinoma. Urology. 2008 May;71(5):915-918.
Sobecks RM, Ball EJ, Askar M, Theil KS, Rybicki LA, Thomas D, Brown S, Kalaycio M, Andresen
S, Pohlman B, Dean R, Sweetenham J, Macklis R, Bernhard L, Cherni K, Copelan E,
Maciejewski JP, Bolwell BJ. Influence of killer immunoglobulin-like receptor/HLA ligand matching
on achievement of T-cell complete donor chimerism in related donor nonmyeloablative allogeneic
hematopoietic stem cell transplantation. Bone Marrow Transplant. 2008 Apr;41(8):709-714.
Sobecks RM, Dean R, Rybicki LA, Chan J, Theil KS, Macklis R, Andresen S, Kalaycio M,
Pohlman B, Ferraro C, Cherni K, Sweetenham J, Copelan E, Bolwell BJ. 400 cGy TBI with
fludarabine for reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation.
Bone Marrow Transplant. 2008 Dec;42(11):715-722.
Soin A, Cheng J, Brown L, Moufawad S, Mekhail N. Functional outcomes in patients with chronic
nonmalignant pain on long-term opioid therapy. Pain Pract. 2008 Sep;8(5):379-384.
Solares CA, Lee WT, Batra PS, Citardi MJ. Lateral lamella of the cribriform plate: softwareenabled computed tomographic analysis and its clinical relevance in skull base surgery. Arch
Otolaryngol Head Neck Surg. 2008 Mar;134(3):285-289.
Somanath PR, Chen J, Byzova TV. Akt1 is necessary for the vascular maturation and
angiogenesis during cutaneous wound healing. Angiogenesis. 2008;11(3):277-288.
Sonpavde G, Hutson TE, Rini BI. Axitinib for renal cell carcinoma. Expert Opin Investig Drugs.
2008 May;17(5):741-748.
Sorkness RL, Bleecker ER, Busse WW, Calhoun WJ, Castro M, Chung KF, Curran-Everett D,
Erzurum SC, Gaston BM, Israel E, Jarjour NN, Moore WC, Peters SP, Teague WG, Wenzel SE.
Lung function in adults with stable but severe asthma: air trapping and incomplete reversal of
obstruction with bronchodilation. J Appl Physiol. 2008 Feb;104(2):394-403.
Stadler WM, Desai AA, Quinn DI, Bukowski R, Poiesz B, Kardinal CG, Lewis N, Makalinao A,
Murray P, Torti FM. A Phase I/II study of GTI-2040 and capecitabine in patients with renal cell
carcinoma. Cancer Chemother Pharmacol. 2008 Apr;61(4):689-694.
Stebbing J, Wood C, Atkins M, Bukowski R, Litwin S, Bower M, Parsa A, Levitsky H. Cancer
vaccines: Clinical development challenges and proposed regulatory approaches for patient
access to promising treatments. Cancer. 2008 Mar 1;112(5):955-961.
Stephenson AJ, Gill IS. Laparoscopic radical cystectomy for muscle-invasive bladder cancer:
pathological and oncological outcomes. BJU Int. 2008 Nov;102(9 Pt B):1296-1301.
Stephenson AJ. Re: Zhao et al.: External validation of University of California, San Francisco,
Cancer of the Prostate Risk Assessment Score (Urology 2008;72:396-400). Urology. 2008
Sep;72(3):719-720.
Stephenson AJ. Is obesity associated with biochemical recurrence in patients with prostate
cancer? Nat Clin Pract Urol. 2008 Feb;5(2):68-69.
Stephenson AJ, Jones JS, Klein EA. Editorial comment [Histopathological findings in extended
prostate biopsy with PSA < or = 4 ng/mL]. Int Braz J Urol. 2008 May-Jun;34(3):291-292.
Stephenson AJ. Is the Phoenix definition superior to ASTRO for predicting clinical outcomes in
prostate cancer? Nat Clin Pract Urol. 2008 Jul;5(7):356-357.
Stevens G, Angelov L. Evaluating and diagnosing spine tumors. Spinal Column. 2008 Spring;1920.
Stone NN, Stock RG, Potters L, Davis BJ, Ciezki JP, Kattan MW, Zelefsky MJ, Fearn PA, Roach
M. In reply to Drs. Oton and Oton [Brachytherapy doses for prostate cancer customized to risk
factors: Is it more important "How much" or "Where"? In Regard to Stone et al. (Int J Radiat Oncol
Biol Phys 2007;69:1472-1477)]. Int J Radiat Oncol Biol Phys. 2008 Jul 1;71(3):962-963.
Stone R, Sekeres M, Garcia-Manero G, Lyons RM. Recent advances in low- and intermediate-1risk myelodysplastic syndrome: developing a consensus for optimal therapy. Clin Adv Hematol
Oncol. 2008 Dec;6(12):1-15.
Su JW, Mason DP, Murthy SC, Rice TW. Closure of a large tracheoesophageal fistula using
AlloDerm. J Thorac Cardiovasc Surg. 2008 Mar;135(3):706-707.
Suardi N, Porter CR, Reuther AM, Walz J, Kodama K, Gibbons RP, Correa R, Montorsi F,
Graefen M, Huland H, Klein EA, Karakiewicz PI. A nomogram predicting long-term biochemical
recurrence after radical prostatectomy. Cancer. 2008 Mar 15;112(6):1254-1263.
Subbiah V, Viny AD, Rosenblatt S, Pohlman B, Lichtin A, Maciejewski JP. Outcomes of
splenectomy in T-cell large granular lymphocyte leukemia with splenomegaly and cytopenia. Exp
Hematol. 2008 Sep;36(9):1078-1083.
Subramanian VS, Gilligan T, Klein EA. A case of spermatic cord teratoma in low-stage testicular
cancer managed by surveillance. Nat Clin Pract Urol. 2008 Apr;5(4):220-223.
Sweetenham JW. Highly aggressive lymphomas in adults. Hematol Oncol Clin North Am. 2008
Oct;22(5):965-978.
Sweetenham JW. Minimizing late effects in children and adults with Hodgkin lymphoma - the
beginning of the end for radiation therapy. Leuk Lymphoma. 2008 May;49(5):839-840.
Swinnen LJ, Rankin C, Carraway H, Albain KS, Townsend JJ, Budd GT, Kish JA, Rivkin SE,
Blumenthal DT. A Phase II study of cisplatin preceded by a 12-h continuous infusion of
concurrent hydroxyurea and cytosine arabinoside (Ara-C) for adult patients with malignant
gliomas (Southwest Oncology Group S9149). J Neurooncol. 2008 Feb;86(3):353-358.
Szpurka H, Schade AE, Jankowska AM, Maciejewski JP. Altered lipid raft composition and
defective cell death signal transduction in glycosylphosphatidylinositol anchor-deficient PIG-A
mutant cells. Br J Haematol. 2008 Aug;142(3):413-422.
Taban M, Lowder CY, Hajj-Ali R, Singh AD. Anterior scleritis as the presenting sign of metastatic
lung cancer. Br J Ophthalmol. 2008 Jan;92(1):147.
Tagawa ST, Dorff TB, Rochanda L, Ye W, Boyle S, Raghavan D, Lieskovsky G, Skinner DG,
Quinn DI, Liebman HA. Subclinical haemostatic activation and current surgeon volume predict
bleeding with open radical retropubic prostatectomy. BJU Int. 2008 Nov;102(9):1086-1091.
Tamai H, Watanabe S, Zheng R, Deguchi K, Cohen PA, Koski GK, Shu S. Effective treatment of
spontaneous metastases derived from a poorly immunogenic murine mammary carcinoma by
combined dendritic-tumor hybrid vaccination and adoptive transfer of sensitized T cells. Clin
Immunol. 2008 Apr;127(1):66-77.
Tamaskar I, Garcia JA, Elson P, Wood L, Mekhail T, Dreicer R, Rini BI, Bukowski RM. Antitumor
effects of sunitinib or sorafenib in patients with metastatic renal cell carcinoma who received prior
antiangiogenic therapy. J Urol. 2008 Jan;179(1):81-86; discussion 86.
Tamaskar I, Bukowski R, Elson P, Ioachimescu AG, Wood L, Dreicer R, Mekhail T, Garcia J, Rini
BI. Thyroid function test abnormalities in patients with metastatic renal cell carcinoma treated
with sorafenib. Ann Oncol. 2008 Feb;19(2):265-268.
Tamaskar I, Mekhail T, Dreicer R, Olencki T, Roman S, Elson P, Bukowski RM. Phase Iota trial
of weekly Docetaxel and daily Temozolomide in patients with metastatic disease. Invest New
Drugs. 2008 Dec;26(6):553-559.
Tamaskar I, Zhou M. Clinical implications of caveolins in malignancy and their potential as
therapeutic targets. Curr Oncol Rep. 2008 Mar;10(2):101-106.
Taniguchi E, Nishijo K, McCleish AT, Michalek JE, Grayson MH, Infante AJ, Abboud HE, Legallo
RD, Qualman SJ, Rubin BP, Keller C. PDGFR-A is a therapeutic target in alveolar
rhabdomyosarcoma. Oncogene. 2008 Nov 20;27(51):6550-6560.
Taylor KL, Leaman DW, Grane R, Mechti N, Borden EC, Lindner DJ. Identification of interferonbeta-stimulated genes that inhibit angiogenesis in vitro. J Interferon Cytokine Res. 2008
Dec;28(12):733-740.
Tendulkar RD, Fleming PA, Reddy CA, Gildea TR, Machuzak M, Mehta AC. High-dose-rate
endobronchial brachytherapy for recurrent airway obstruction from hyperplastic granulation
tissue. Int J Radiat Oncol Biol Phys. 2008 Mar 1;70(3):701-706.
Teresi RE, Planchon SM, Waite KA, Eng C. Regulation of the PTEN promoter by statins and
SREBP. Hum Mol Genet. 2008 Apr 1;17(7):919-928.
Thakkar SG, Fu AZ, Sweetenham JW, McIver ZA, Mohan SR, Ramsingh G, Advani AS, Sobecks
R, Rybicki L, Kalaycio M, Sekeres MA. Survival and predictors of outcome in patients with acute
leukemia admitted to the intensive care unit. Cancer. 2008 May 15;112(10):2233-2240.
Thomas AA, Rackley RR, Lee U, Goldman HB, Vasavada SP, Hansel DE. Urethral diverticula in
90 female patients: a study with emphasis on neoplastic alterations. J Urol. 2008
Dec;180(6):2463-2467.
Tilluckdharry L, Dean R, Farver C, Ahmad M. Thalidomide-related eosinophilic pneumonia: A
case report and brief literature review. Cases J. 2008 Sep 8;1(1):143.
Tiu RV, Sekeres MA. The role of AMG-531 in the treatment of thrombocytopenia in idiopathic
thrombocytopenic purpura and myelodysplastic syndromes. Expert Opin Biol Ther. 2008
Jul;8(7):1021-1030.
Toms SA, Weil RJ, Gupta A, Boulis NM, Prayson R, Lang FF. Clinical problem-solving: island
intruder. Neurosurgery. 2008 Apr;62(4):920-928; discussion 928-929.
Townsend HL, Jha BK, Han JQ, Maluf NK, Silverman RH, Barton DJ. A viral RNA competitively
inhibits the antiviral endoribonuclease domain of RNase L. RNA. 2008 Jun;14(6):1026-1036.
Townsend HL, Jha BK, Silverman RH, Barton DJ. A putative loop E motif and an H-H kissing
loop interaction are conserved and functional features in a group C enterovirus RNA that inhibits
ribonuclease L. RNA Biol. 2008 Oct;5(4):263-272.
Trabulsi EJ, Valicenti RK, Hanlon AL, Pisansky TM, Sandler HM, Kuban DA, Catton CN,
Michalski JM, Zelefsky MJ, Kupelian PA, Lin DW, Anscher MS, Slawin KM, Roehrborn CG,
Forman JD, Liauw SL, Kestin LL, DeWeese TL, Scardino PT, Stephenson AJ, Pollack A. A multiinstitutional matched-control analysis of adjuvant and salvage postoperative radiation therapy for
pT3-4N0 prostate cancer. Urology. 2008 Dec;72(6):1298-1302.
Triozzi PL, Eng C, Singh AD. Targeted therapy for uveal melanoma. Cancer Treat Rev. 2008
May;34(3):247-258.
Triozzi PL, Aldrich W, Dombos C. Differential effects of imatinib mesylate against uveal
melanoma in vitro and in vivo. Melanoma Res. 2008 Dec;18(6):420-430.
Ueno NT, Rizzo JD, Demirer T, Cheng YC, Hegenbart U, Zhang MJ, Bregni M, Carella A, Blaise
D, Bashey A, Bitran JD, Bolwell BJ, Elfenbein GJ, Fields KK, Freytes CO, Gale RP, Lazarus HM,
Champlin RE, Stiff PJ, Niederwieser D. Allogeneic hematopoietic cell transplantation for
metastatic breast cancer. Bone Marrow Transplant. 2008 Mar;41(6):537-545.
Uetani K, Hiroi M, Meguro T, Ogawa H, Kamisako T, Ohmori Y, Erzurum SC. Influenza A virus
abrogates IFN-gamma response in respiratory epithelial cells by disruption of the Jak/Stat
pathway. Eur J Immunol. 2008 Jun;38(6):1559-1573.
Vakkalanka BK, Bukowski RM. Novel drugs for renal cell carcinoma. Expert Opin Investig Drugs.
2008 Oct;17(10):1501-1516.
Vakkalanka BK, Rini BI. Targeted therapy in renal cell carcinoma. Curr Opin Urol. 2008
Sep;18(5):481-487.
Valiyaveettil M, Kar N, Ashraf MZ, Byzova TV, Febbraio M, Podrez EA. Oxidized high-density
lipoprotein inhibits platelet activation and aggregation via scavenger receptor BI. Blood. 2008 Feb
15;111(4):1962-1971.
Vatolin S, Weil RJ. Extension of endogenous primers as a tool to detect micro-RNA targets.
Methods Enzymol. 2008;449:357-371.
Vickers AJ, Bianco FJ, Gonen M, Cronin AM, Eastham JA, Schrag D, Klein EA, Reuther AM,
Kattan MW, Pontes JE, Scardino PT. Effects of pathologic stage on the learning curve for radical
prostatectomy: evidence that recurrence in organ-confined cancer is largely related to inadequate
surgical technique. Eur Urol. 2008 May;53(5):960-966.
Videtic GM. Primary malignant mesothelioma of the abdominal wall: complete response with
radiotherapy alone. Technol Cancer Res Treat. 2008 Feb;7(1):41-44.
Videtic GMM, Belderbos JSA, Kong FM, Kepka L, Martel MK, Jeremic B. Report from the
International Atomic Energy Agency (IAEA) consultants' meeting on elective nodal irradiation in
lung cancer: non-small-Cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys. 2008 Oct
1;72(2):327-334.
Videtic GMM, Rice TW, Murthy S, Suh JH, Saxton JP, Adelstein DJ, Mekhail TM. Utility of
positron emission tomography compared with mediastinoscopy for delineating involved lymph
nodes in stage III lung cancer: insights for radiotherapy planning from a surgical cohort. Int J
Radiat Oncol Biol Phys. 2008 Nov 1;72(3):702-706.
Villalona-Calero MA, Otterson GA, Wientjes MG, Weber F, Bekaii-Saab T, Young D, Murgo AJ,
Jensen R, Yeh TK, Wei Y, Zhang Y, Eng C, Grever M, Au JL. Noncytotoxic suramin as a
chemosensitizer in patients with advanced non-small-cell lung cancer: a phase II study. Ann
Oncol. 2008 Nov;19(11):1903-1909.
Villarruel SM, Boehm CA, Pennington M, Bryan JA, Powell KA, Muschler GF. The effect of
oxygen tension on the in vitro assay of human osteoblastic connective tissue progenitor cells. J
Orthop Res. 2008 Oct;26(10):1390-1397.
Viny AD, Lichtin A, Pohlman B, Loughran T, Maciejewski J. Chronic B-cell dyscrasias are an
important clinical feature of T-LGL leukemia. Leuk Lymphoma. 2008 May;49(5):932-938.
Wang J, Wang H, Li Z, Wu Q, Lathia JD, McLendon RE, Hjelmeland AB, Rich JN. c-Myc is
required for maintenance of glioma cancer stem cells. PLoS ONE. 2008;3(11):e3769.
Watanabe S, Deguchi K, Zheng R, Tamai H, Wang LX, Cohen PA, Shu S. Tumor-induced
CD11b+Gr-1+ myeloid cells suppress T cell sensitization in tumor-draining lymph nodes. J
Immunol. 2008 Sep 1;181(5):3291-3300.
Weaver J, Downs-Kelly E, Goldblum JR, Turner S, Kulkarni S, Tubbs RR, Rubin BP, Skacel M.
Fluorescence in situ hybridization for MDM2 gene amplification as a diagnostic tool in lipomatous
neoplasms. Mod Pathol. 2008 Aug;21(8):943-949.
Weber F, Eng C. Update on the molecular diagnosis of endocrine tumors: Toward -omics-based
personalized healthcare? J Clin Endocrinol Metab. 2008 Apr;93(4):1097-1104.
Weight CJ, Reuther AM, Gunn PW, Zippe CR, Dhar NB, Klein EA. Limited pelvic lymph node
dissection does not improve biochemical relapse-free survival at 10 years after radical
prostatectomy in patients with low-risk prostate cancer. Urology. 2008 Jan;71(1):141-145.
Weight CJ, Kaouk JH, Hegarty NJ, Remer EM, O'Malley CM, Lane BR, Gill IS, Novick AC.
Correlation of radiographic imaging and histopathology following cryoablation and radio frequency
ablation for renal tumors. J Urol. 2008 Apr;179(4):1277-1281;discussion 1281-1283.
Weight CJ, Klein EA, Jones JS. Androgen deprivation falls as orchiectomy rates rise after
changes in reimbursement in the U.S. Medicare population. Cancer. 2008 May 15;112(10):21952201.
Weight CJ, Fergany AF, Gunn PW, Lane BR, Novick AC. The impact of minimally invasive
techniques on open partial nephrectomy: a 10-year single institutional experience. J Urol. 2008
Jul;180(1):84-88.
Weil RJ. Incorporating molecular tools into early-stage clinical trials. PLoS Med. 2008 Jan
22;5(1):e21.
Weinreb I, Rubin BP, Goldblum JR. Pleomorphic angiomatoid fibrous histiocytoma: a case
confirmed by fluorescence in situ hybridization analysis for EWSR1 rearrangement. J Cutan
Pathol. 2008 Sep;35(9):855-860.
Weiss PA. Does smoking marijuana contribute to the risk of developing lung cancer? Clin J
Oncol Nurs. 2008 Jun;12(3):517-519.
Weiss PA. Does milk cause cancer? Clin J Oncol Nurs. 2008 Apr;12(2):359-360.
Weiss PA. Can chemotherapy dosing be individualized? Clin J Oncol Nurs. 2008 Dec;12(6):975977.
Weiss PA. Should insurance be responsible for the cost of care while a patient is enrolled in a
clinical trial? Clin J Oncol Nurs. 2008 Jan;12(1):153-154.
Weissman JR, Kelley RI, Bauman ML, Cohen BH, Murray KF, Mitchell RL, Kern RL, Natowicz
MR. Mitochondrial disease in autism spectrum disorder patients: a cohort analysis. PLoS ONE.
2008;3(11):e3815.
Wesa AK, Herrem CJ, Mandic M, Taylor JL, Vasquez C, Kawabe M, Tatsumi T, Leibowitz MS,
Finke JH, Bukowski RM, Bruckheimer E, Kinch MS, Storkus WJ. Enhancement in specific CD8+
T cell recognition of EphA2+ tumors in vitro and in vivo after treatment with ligand agonists. J
Immunol. 2008 Dec 1;181(11):7721-7727.
Wilkinson DA, Kolar M, Fleming PA, Singh AD. Dosimetric comparison of 106Ru and 125I
plaques for treatment of shallow (<or=5 mm) choroidal melanoma lesions. Br J Radiol. 2008
Oct;81(970):784-789.
Williams PS, Hoyos M, Kurowski P, Salhi D, Moore LR, Zborowski M. Characterization of
nonspecific crossover in split-flow thin channel fractionation. Anal Chem. 2008 Sep
15;80(18):7105-7115.
Wlodarski MW, Nearman Z, Jankowska A, Babel N, Powers J, Leahy P, Volk HD, Maciejewski
JP. Phenotypic differences between healthy effector CTL and leukemic LGL cells support the
notion of antigen-triggered clonal transformation in T-LGL leukemia. J Leukoc Biol. 2008
Mar;83(3):589-601.
Wlodarski MW, Nearman Z, Jiang Y, Lichtin A, Maciejewski JP. Clonal predominance of CD8(+)
T cells in patients with unexplained neutropenia. Exp Hematol. 2008 Mar;36(3):293-300.
Wolf PS, Flum DR, Tanas MR, Rubin BP, Mann GN. Epithelioid sarcoma: the University of
Washington experience. Am J Surg. 2008 Sep;196(3):407-412.
Wood C, Srivastava P, Bukowski R, Lacombe L, Gorelov AI, Gorelov S, Mulders P, Zielinski H,
Hoos A, Teofilovici F, Isakov L, Flanigan R, Figlin R, Gupta R, Escudier B. An adjuvant
autologous therapeutic vaccine (HSPPC-96; vitespen) versus observation alone for patients at
high risk of recurrence after nephrectomy for renal cell carcinoma: a multicentre, open-label,
randomised phase III trial. Lancet. 2008 Jul 12;372(9633):145-154.
Wood HM, Kay R, Angermeier KW, Ross JH. Timing of the presentation of urethrocutaneous
fistulas after hypospadias repair in pediatric patients. J Urol. 2008 Oct;180(4 Suppl):1753-1756.
Wood LS. The author responds [Reader seeks clarification on hand-foot skin reaction]. Clin J
Oncol Nurs. 2008 Jun;12(3):395.
Wu L, Yong SL, Fan C, Ni Y, Yoo S, Zhang T, Zhang X, Obejero-Paz CA, Rho HJ, Ke T,
Szafranski P, Jones SW, Chen Q, Wang QK. Identification of a new co-factor, MOG1, required
for the full function of cardiac sodium channel Nav1.5. J Biol Chem. 2008 Mar 14;283(11):69686978.
Wu Y, Shi X, Guo SW. The knockdown of progesterone receptor isoform B (PR-B) promotes
proliferation in immortalized endometrial stromal cells. Fertil Steril. 2008 Oct;90(4):1320-1323.
Wu Y, Starzinski-Powitz A, Guo SW. Capsaicin inhibits proliferation of endometriotic cells in vitro.
Gynecol Obstet Invest. 2008;66(1):59-62.
Yang B, Pretorius RG, Belinson JL, Zhang X, Burchette R, Qiao YL. False negative colposcopy
is associated with thinner cervical intraepithelial neoplasia 2 and 3. Gynecol Oncol. 2008
Jul;110(1):32-36.
Yang XJ, Zhou M, Hes O, Shen S, Li R, Lopez J, Shah RB, Yang Y, Chuang ST, Lin F,
Tretiakova MM, Kort EJ, Teh BT. Tubulocystic carcinoma of the kidney: clinicopathologic and
molecular characterization. Am J Surg Pathol. 2008 Feb;32(2):177-187.
Yao V, Parwani A, Maier C, Heston WD, Bacich DJ. Moderate expression of prostate-specific
membrane antigen, a tissue differentiation antigen and folate hydrolase, facilitates prostate
carcinogenesis. Cancer Res. 2008 Nov 1;68(21):9070-9077.
Yee-Guardino S, Gowans K, Yen-Lieberman B, Berk P, Kohn D, Wang FZ, nziger-Isakov L,
Sabella C, Worley S, Pellett PE, Goldfarb J. Beta-herpesviruses in febrile children with cancer.
Emerg Infect Dis. 2008 Apr;14(4):579-585.
Yesenko SL, Gornik HL, Henion D, Bartholomew JR. Findings of brain death with the use of
carotid duplex ultrasonography. Journal for Vascular Ultrasound. 2008 Sep;32(3):152-156.
Yi T, Lindner D. The role and target potential of protein tyrosine phosphatases in cancer. Curr
Oncol Rep. 2008 Mar;10(2):114-121.
Zafereo ME, Fakhri S, Prayson R, Batra PS, Lee J, Lanza DC, Citardi MJ.
Esthesioneuroblastoma: 25-year experience at a single institution. Otolaryngol Head Neck Surg.
2008 Apr;138(4):452-458.
Zama IN, Maynard WK, Davis MP. Clocking delirium: the value of the clock drawing test with
case illustrations. Am J Hosp Palliat Care. 2008 Oct;25(5):385-388.
Zamanian-Daryoush M, Marques JT, Gantier MP, Behlke MA, John M, Rayman P, Finke J,
Williams BRG. Determinants of cytokine induction by small interfering RNA in human peripheral
blood mononuclear cells. J Interferon Cytokine Res. 2008 Apr;28(4):221-233.
Zhang S, Yin K, Ren X, Wang P, Zhang S, Cheng L, Yang J, Liu JY, Liu M, Wang QK.
Identification of a novel KCNQ1 mutation associated with both Jervell and Lange-Nielsen and
Romano-Ward forms of long QT syndrome in a Chinese family. BMC Med Genet. 2008;9:24.
Zhang S, Liu M, Dong JM, Yin K, Wang P, Bu J, Li J, Hao YS, Hao P, Wang QK, Wang L.
Identification of a genetic locus for autosomal dominant infantile cataract on chromosome
20p12.1-p11.23 in a Chinese family. Mol Vis. 2008;14:1893-1897.
Zhang S, Wang L, Hao Y, Wang P, Hao P, Yin K, Wang QK, Liu M. T14484C and T14502C in
the mitochondrial ND6 gene are associated with Leber's hereditary optic neuropathy in a Chinese
family. Mitochondrion. 2008 Jun;8(3):205-210.
Zhang X, Chen S, Zhang L, Liu M, Redfearn S, Bryant RM, Oberti C, Vincent GM, Wang QK.
Protective effect of KCNH2 single nucleotide polymorphism K897T in LQTS families and
identification of novel KCNQ1 and KCNH2 mutations. BMC Med Genet. 2008;9:87.
Zhang X, Chen S, Yoo S, Chakrabarti S, Zhang T, Ke T, Oberti C, Yong SL, Fang F, Li L, de la
Fuente R, Wang L, Chen Q, Wang QK. Mutation in nuclear pore component NUP155 leads to
atrial fibrillation and early sudden cardiac death. Cell. 2008 Dec 12;135(6):1017-1027.
Zheng R, Cohen PA, Paustian CA, Johnson TD, Lee WT, Shu S, Koski GK. Paired Toll-like
receptor agonists enhance vaccine therapy through induction of interleukin-12. Cancer Res. 2008
Jun 1;68(11):4045-4049.
Zhou J, Febbraio M, Wada T, Zhai Y, Kuruba R, He J, Lee JH, Khadem S, Ren S, Li S,
Silverstein RL, Xie W. Hepatic fatty acid transporter Cd36 is a common target of LXR, PXR, and
PPARgamma in promoting steatosis. Gastroenterology. 2008 Feb;134(2):556-567.
Zhou Y, Weyman CM, Liu H, Almasan A, Zhou A. IFN-gamma induces apoptosis in HL-60 cells
through decreased Bcl-2 and increased Bak expression. J Interferon Cytokine Res. 2008
Feb;28(2):65-72.
Whole Books and Monographic Serials
Bukowski RM, Novick AC. Clinical Management of Renal Tumors. Totowa, NJ: Humana Press;
2008.
Falk GW. An Update on Esophageal Diseases. Philadelphia, PA: W.B. Saunders Company;
2008
Hatton C, Collins G, Sweetenham J. Fast Facts : Lymphoma. Abingdon, UK: Health Press; 2008.
Klein EA. Prostate Cancer : a Cleveland Clinic Guide. Cleveland, OH: Cleveland Clinic Press;
2008.
Montague DK, Gill IS, Angermeier KW, Ross JH. Textbook of Reconstructive Urologic Surgery.
London, [England]: Informa Healthcare; 2008.
Nargund VH, Raghavan D, Sandler HM. Urological Oncology. London, [England]: Springer;
2008.
Patterson GA, Cooper JD, Deslauriers J, Lerut AEMR, Luketich JD, Rice TW. Pearson's
Thoracic & Esophageal Surgery. 3rd ed. Philadelphia, PA: Churchill Livingstone/Elsevier; 2008.
Raghavan D, Tuthill K. Bladder Cancer : a Cleveland Clinic Guide : Information for Patients and
Caregivers. Cleveland, OH: Cleveland Clinic Press; 2008.
Zborowski M, Chalmers JJ. Magnetic Cell Separation. Amsterdam, Netherlands: Elsevier; 2008.
Book Chapters
Abdu A, Narouze S, Mekhail N. Pain management in chronic prostatitis. In: Shoskes DA, ed.
Chronic Prostatitis/Chronic Pelvic Pain Syndrome. Totowa, NJ: Humana Press; 2008:165-174.
Adelstein DJ, Videtic GMM, Mekhail T. Definitive management of inoperable non-small cell lung
cancer. In: Patterson GA, ed. Pearson's Thoracic & Esophageal Surgery. 3rd ed. Philadelphia,
PA: Churchill Livingstone/Elsevier; 2008:804-821.
Al-Hazzouri A, Herts BR, Bukowski RM. Renal cell carcinoma metastatic to the pancreas:
Clinical and therapeutic aspects. In: Bukowski RM, Novick AC, eds. Clinical Management of
Renal Tumors. Totowa, NJ: Humana Press; 2008:461-480.
Borden EC, Silverman RH, Sen G. Interferons. In: Mendelsohn J, ed. The Molecular Basis of
Cancer. 3rd ed. Philadelphia, PA: Saunders/Elsevier; 2008:621-633.
Bukowski RM. Adjuvant therapy of renal cell carcinoma. In: Bukowski RM, Novick AC, eds.
Clinical Management of Renal Tumors. Totowa, NJ: Humana Press; 2008:293-306.
Celestin CA, Bartholomew JR. Heparin-induced thrombocytopenia. In: van de Weert M, Moller
EH, eds. Immunogenicity of Biopharmaceuticals. New York, NY: Springer; 2008:205-238.
Chernausek SD, Eng C. Pheochromocytoma and the multiple endocrine neoplasia syndromes.
In: Sperling MA, ed. Pediatric Endocrinology. 3rd ed. Philadelphia, PA: Saunders/Elsevier;
2008:512-529.
Citardi MJ, Batra PS. The nose and paranasal sinuses. In: Lee KJ, ed. Essential Otolaryngology
: Head & Neck Surgery. 9th ed. New York, NY: McGraw-Hill; 2008:365-412.
Citardi MJ, Batra PS. Revision image-guided functional endoscopic sinus surgery. In: Kountakis
SE, Jacobs JB, Gosepath J, eds. Revision Sinus Surgery. Berlin ; London: Springer; 2008:251267.
Crosby ME, Plesca D, Almasan A. E2F4 role in the therapeutic response: Beyond the cell cycle.
In: Yoshida K, ed. Control of Cellular Physiology by E2F Transciption Factors. Kerala, India:
Research Signpost; 2008:401-412.
Davis MP, Smith HS. Opioid pharmacology. In: Smith HS, ed. Opioid Therapy in the 21st
Century. Oxford ; New York, NY: Oxford University Press; 2008:19-26.
Davis MP, Smith HS. Opioid therapy for cancer pain. In: Smith HS, ed. Opioid Therapy in the
21st Century. Oxford ; New York, NY: Oxford University Press; 2008:77-89.
Davis MP. Palliation in renal cancer. In: Bukowski RM, Novick AC, eds. Clinical Management of
Renal Tumors. Totowa, NJ: Humana Press; 2008:507-528.
Diulus CA, Shedid D, Lieberman IH. Osteotomies for correction of pediatric spine deformities. In:
Kim DH, ed. Surgery of the Pediatric Spine. New York, NY: Thieme; 2008:742-753.
Estey EH, Sobecks RM, Theil KS. Myelodysplastic syndromes. In: Markman M, ed. Atlas of
Cancer. 2nd ed. Philadelphia, PA: Current Medicine Group LLC/Springer; 2008:286-295.
Estey EH, Kalaycio M. Acute myelogenous leukemia. In: Markman M, ed. Atlas of Cancer. 2nd
ed. Philadelphia, PA: Current Medicine Group LLC/Springer; 2008:296-303.
Fergany AF, Novick AC. Surgery for renal vascular disease. In: Montague DK, ed. Textbook of
Reconstructive Urologic Surgery. London, [England]: Informa Healthcare; 2008:121-126.
Finke JH, Goel M. T-cell unresponsiveness in renal cell carcinoma patients. In: Bukowski RM,
Novick AC, eds. Clinical Management of Renal Tumors. Totowa, NJ: Humana Press; 2008:115130.
Foran JM, Sekeres MA. Myelodysplastic syndromes. In: Abeloff MD, ed. Abeloff's Clinical
Oncology. 4th ed. Philadelphia, PA: Churchill Livingstone/Elsevier; 2008:2235-2259.
Garcia JA, Dreicer R. Transitional cell carcinoma of the renal pelvis: Management. In: Bukowski
RM, Novick AC, eds. Clinical Management of Renal Tumors. Totowa, NJ: Humana Press;
2008:587-597.
Gilligan T. Prostate cancer. In: Glare P, Christakis NA, eds. Prognosis in Advanced Cancer.
Oxford ; New York, NY: Oxford University Press; 2008:143-150.
Gretter B, Mekhail N. Intradiskal procedures for the management of low back pain. In: Benzon
HT, ed. Raj's Practical Management of Pain. 4th ed. Philadelphia, PA: Mosby-Elsevier;
2008:1109-1117.
Gupta D, Arora R, Mohan RR, Almasan A, Gudkov AV, Macklis RM. Novel strategies for
protecting mitochondria (the cellular powerhouse) against low-LET radiation : a review. In: Arora
R, ed. Herbal Radiomodulators : Applications in Medicine, Homeland Defence and Space.
Wallingford, UK ; Cambridge, MA: CABI; 2008:215-226.
Haddad A, Maciejewski JP. Aplastic anemia. In: Rakel RE, Bope ET, eds. Conn's Current
Therapy 2008 : Latest Approved Methods of Treatment for the Practicing Physician. [60th] ed.
Philadelphia, PA: Saunders Elsevier; 2008:381-385.
Joyce MJ. Management of skeletal metastases in renal cell carcinoma patients. In: Bukowski
RM, Novick AC, eds. Clinical Management of Renal Tumors. Totowa, NJ: Humana Press;
2008:421-459.
Kalmadi S, Raghavan D. Principles of chemotherapy for genitourinary cancer. In: Nargund VH,
Raghavan D, Sandler HM, eds. Urological Oncology. London, [England]: Springer; 2008:194212.
Kang TY, Sweetenham JW. Lymphoblastic lymphoma. In: Crowther M, ed. Evidence-Based
Hematology. Chichester, UK ; Hoboken, NJ: Wiley-Blackwell; 2008:342-346.
Klimm B, Engert A, Pohlman B, Hsi ED. Hodgkin lymphoma. In: Markman M, ed. Atlas of
Cancer. 2nd ed. Philadelphia, PA: Current Medicine Group LLC/Springer; 2008:346-357.
Linehan WM, Rini BI, Yang JC. Cancer of the kidney. In: DeVita VT Jr, Lawrence TS, Rosenberg
SA, eds. DeVita, Hellman, and Rosenberg's Cancer : Principles & Practice of Oncology. 8th ed.
Philadelphia, PA: Wolters Kluwer/Lippincott Williams & Wilkins; 2008:1331-1358.
Lo SS, Chao ST, Suh JH. 3D conformal RT. In: Jeremic B, Pitz S, eds. Primary Optic Nerve
Sheath Meningioma. New York, NY: Springer; 2008:85-94.
Lorenz RR, Netterville JL, Burkey BB. Head and neck. In: Townsend CM Jr, ed. Sabiston
Textbook of Surgery: the Biological Basis of Modern Surgical Practice. 18th ed. Philadelphia, PA:
Saunders/Elsevier; 2008:813-847.
Lorenz RR, Strome M. Laryngeal transplantation. In: Hewitt CW, Lee WPA, Gordon CR, eds.
Transplantation of Composite Tissue Allografts. New York, NY: Springer; 2008:330-343.
Mahadevan A. Role of radiation therapy in advanced renal cell carcinoma. In: Bukowski RM,
Novick AC, eds. Clinical Management of Renal Tumors. Totowa, NJ: Humana Press; 2008:497505.
Majhail NS, Bukowski RM. Functional imaging of renal cell carcinoma. In: Bukowski RM, Novick
AC, eds. Clinical Management of Renal Tumors. Totowa, NJ: Humana Press; 2008:323-333.
McNeil BK, Campbell SC. Local recurrence of renal cell carcinoma: Management. In: Bukowski
RM, Novick AC, eds. Clinical Management of Renal Tumors. Totowa, NJ: Humana Press;
2008:275-292.
Mekhail T, Tiu R. Hematology and oncology. In: Rolston DDK, Nielsen C, eds. Rapid Review
USMLE Step 3. Philadelphia, PA: Mosby/Elsevier; 2008:362-397.
Minzter BH, Cahana A. Organizing an inpatient acute pain management service. In: Benzon HT,
ed. Raj's Practical Management of Pain. 4th ed. Philadelphia, PA: Mosby-Elsevier; 2008:19-44.
Nakamoto M, Ukimura O, Gill IS, Mahadevan A, Miki T, Hashizume M, Sato Y. Realtime organ
tracking for endoscopic augmented reality visualization using miniature wireless magnetic tracker.
In: Dohi T, Sakuma I, Liao H, eds. Medical Imaging and Augmented Reality: 4th International
Workshop Tokyo, Japan, August 1-2, 2008 Proceedings. Berlin ; New York, NY: Springer;
2008:359-366.
Nickles Fader A, Belinson J. Ovarian cancer. In: Rakel RE, Bope ET, eds. Conn's Current
Therapy 2008 : Latest Approved Methods of Treatment for the Practicing Physician. [60th] ed.
Philadelphia, PA: Saunders Elsevier; 2008:1079-1081.
Novakovic KR, Campbell SC. Rare malignancies of the kidney: Evaluation and management. In:
Bukowski RM, Novick AC, eds. Clinical Management of Renal Tumors. Totowa, NJ: Humana
Press; 2008:617-636.
Novick AC. Open partial nephrectomy for kidney cancer. In: Montague DK, ed. Textbook of
Reconstructive Urologic Surgery. London, [England]: Informa Healthcare; 2008:101-107.
Rackley RR, Ross JH, Abdelmalak J. Augmentation cystoplasty: open and laparoscopic
approaches. In: Montague DK, ed. Textbook of Reconstructive Urologic Surgery. London,
[England]: Informa Healthcare; 2008:289-295.
Raghavan D, Sandler HM. Multidisciplinary care of invasive bladder cancer: Emerging roles of
chemotherapy. In: Nargund VH, Raghavan D, Sandler HM, eds. Urological Oncology. London,
[England]: Springer; 2008:361-376.
Raghavan D. Testis. In: Loue S, Sajatovic M, eds. Encyclopedia of Aging and Public Health.
New York, NY: Springer; 2008:776-777.
Raghavan D. Hormone-refractory prostate cancer: A rational approach to chemotherapy. In:
Nargund VH, Raghavan D, Sandler HM, eds. Urological Oncology. London, [England]: Springer;
2008:536-543.
Raghavan D. Testicular cancer. In: Loue S, Sajatovic M, eds. Encyclopedia of Aging and Public
Health. New York, NY: Springer; 2008:775-776.
Raghavan D. Bladder cancer. In: Loue S, Sajatovic M, eds. Encyclopedia of Aging and Public
Health. New York, NY: Springer; 2008:158-160.
Raghavan D. Prostate cancer. In: Loue S, Sajatovic M, eds. Encyclopedia of Aging and Public
Health. New York, NY: Springer; 2008:676-679.
Raghavan D. Prostate. In: Loue S, Sajatovic M, eds. Encyclopedia of Aging and Public Health.
New York, NY: Springer; 2008:675-676.
Raghavan D. Male reproductive function, aging and testosterone replacement. In: Loue S,
Sajatovic M, eds. Encyclopedia of Aging and Public Health. New York, NY: Springer; 2008:517.
Rice TW. Diagnosis and staging of esophageal cancer. In: Patterson GA, ed. Pearson's
Thoracic & Esophageal Surgery. 3rd ed. Philadelphia, PA: Churchill Livingstone/Elsevier;
2008:454-463.
Rice TW, Zuccaro G Jr. Endoscopic ultrasonography. In: Patterson GA, ed. Pearson's Thoracic
& Esophageal Surgery. 3rd ed. Philadelphia, PA: Churchill Livingstone/Elsevier; 2008:97-110.
Rice TW. Anatomy of the lung. In: Patterson GA, ed. Pearson's Thoracic & Esophageal Surgery.
3rd ed. Philadelphia, PA: Churchill Livingstone/Elsevier; 2008:401-414.
Rice TW. Surgical therapy for the columnar-lines esophagus: Non-neoplastic Barrett's
esophagus. In: Patterson GA, ed. Pearson's Thoracic & Esophageal Surgery. 3rd ed.
Philadelphia, PA: Churchill Livingstone/Elsevier; 2008:419-422.
Rice TW. Dilation of peptic esophageal strictures. In: Patterson GA, ed. Pearson's Thoracic &
Esophageal Surgery. 3rd ed. Philadelphia, PA: Churchill Livingstone/Elsevier; 2008:251-260.
Rini BI, Bukowski R. Nonsurgical management of metastatic renal cell carcinoma. In: Nargund
VH, Raghavan D, Sandler HM, eds. Urological Oncology. London, [England]: Springer;
2008:281-297.
Ronnen EA, George S, Bukowski RM, Motzer RJ. Signal transduction inhibitors in renal cell
carcinoma. In: Bukowski RM, Novick AC, eds. Clinical Management of Renal Tumors. Totowa,
NJ: Humana Press; 2008:399-413.
Ross JH. Wilms' tumor in children and adults. In: Bukowski RM, Novick AC, eds. Clinical
Management of Renal Tumors. Totowa, NJ: Humana Press; 2008:599-616.
Ross JH. Complex hypospadias repair. In: Montague DK, ed. Textbook of Reconstructive
Urologic Surgery. London, [England]: Informa Healthcare; 2008:419-425.
Sekeres MA, Stone RM. The acute leukemias. In: Irwin RS, Rippe JM, eds. Irwin and Rippe's
Intensive Care Medicine. 6th ed. Philadelphia, PA: Wolters Kluwer Health/Lippincott Williams &
Wilkins; 2008:1408-1417.
Shedid D, Lieberman IH. Kyphoplasty. In: Vaccaro AR, Baron EM, eds. Spine Surgery.
Philadelphia, PA: Saunders/Elsevier; 2008:429-436.
Shepard D. Otorhinolaryngology. In: Rolston DDK, Nielsen C, eds. Rapid Review USMLE Step
3. Philadelphia, PA: Mosby/Elsevier; 2008:45-59.
Siemionow K, Lieberman IH. Vertebral augmentation and radiosurgery in the treatment of
osteolytic vertebral fracture. In: Gunzburg R, Szpalski M, Aebi M, eds. Vertebral Tumors.
Philadelphia, PA: Lippincott Williams and Wilkins; 2008:157-169.
Siker ML, Donahue BR, Vogelbaum MA, Tome WA, Gilbert MR, Mehta MP. Primary intracranial
neoplasms. In: Halperin EC, Perez CA, Brady LW, eds. Perez and Brady's Principles and
Practice of Radiation Oncology. 5th ed. Philadelphia, PA: Wolters Kluwer Health/Lippincott
Williams & Wilkins; 2008:717-750.
Simmons MN, Campbell SC. Continent cutaneous urinary diversion: right colonic reservoirs. In:
Montague DK, ed. Textbook of Reconstructive Urologic Surgery. London, [England]: Informa
Healthcare; 2008:375-382.
Singh AD, Sisley K, Wackernagel W. Genetics of uveal melanoma. In: Albert DM, ed. Albert &
Jakobiec's Principles and Practice of Ophthalmology. 3rd ed. Philadelphia, PA:
Saunders/Elsevier; 2008:4925-4934.
Soin A, Mekhail N. Minimally invasive procedures for vertebral compression fractures. In: Benzon
HT, ed. Raj's Practical Management of Pain. 4th ed. Philadelphia, PA: Mosby-Elsevier;
2008:1119-1126.
Suh JH, Barnett GH, Regine WF. Brain metastasis. In: Chin LS, Regine WF, eds. Principles and
Practice of Stereotactic Radiosurgery. New York, NY: Springer; 2008:181-191.
Tendulkar RD, Chidel MA, Macklis RM. Tumors of the heart and great vessels. In: Halperin EC,
Perez CA, Brady LW, eds. Perez and Brady's Principles and Practice of Radiation Oncology. 5th
ed. Philadelphia, PA: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2008:1154-1161.
Traboulsi EI, Singh AD. The phakomatoses. In: Albert DM, ed. Albert & Jakobiec's Principles
and Practice of Ophthalmology. 3rd ed. Philadelphia, PA: Saunders/Elsevier; 2008:5009-5024.
Videtic GMM. Targeted therapies in lung cancer. In: Small W Jr, ed. Combining Targeted
Biological Agents With Radiotherapy : Current Status and Future Directions. New York, NY:
Demos Medical Pub.; 2008:139-162.
Wackernagel W, Rao NA, Steinert RF, Singh AD. Optical coherence tomography for anterior
segment tumors. In: Steinert RF, Huang D, eds. Anterior Segment Optical Coherence
Tomography. Thorofare, NJ: SLACK; 2008:127-136.
Wang QK. Atrial fibrillation genetic considerations: the basic scientist's perspective. In: Natale A,
Jalife J, eds. Atrial Fibrillation : From Bench to Bedside. Totowa, NJ: Humana Press; 2008:133144.
Yavuzsen T, Davis MP. Cancer-related fatigue. In: Glare P, Christakis NA, eds. Prognosis in
Advanced Cancer. Oxford ; New York, NY: Oxford University Press; 2008:401-409.
Zborowski M. Magnetic susceptibility. In: Zborowski M, Chalmers JJ, eds. Magnetic Cell
Separation. Amsterdam, Netherlands: Elsevier; 2008:1-28.
Zborowski M, Williams PS, Moore LR, Chalmers JJ, Zimmerman PA. New challenges and
opportunities. In: Zborowski M, Chalmers JJ, eds. Magnetic Cell Separation. Amsterdam,
Netherlands: Elsevier; 2008:331-412.
Zborowski M. Commercial magnetic cell separation instruments and reagents. In: Zborowski M,
Chalmers JJ, eds. Magnetic Cell Separation. Amsterdam, Netherlands: Elsevier; 2008:265-292.
Zborowski M, Chalmers JJ. Preface [Magnetic cell separation]. In: Zborowski M, Chalmers JJ,
eds. Magnetic Cell Separation. Amsterdam, Netherlands: Elsevier; 2008.
Zborowski M. Maxwell stress and magnetic force. In: Zborowski M, Chalmers JJ, eds. Magnetic
Cell Separation. Amsterdam, Netherlands: Elsevier; 2008:63-79.
Zborowski M. Magnetophoresis. In: Zborowski M, Chalmers JJ, eds. Magnetic Cell Separation.
Amsterdam, Netherlands: Elsevier; 2008:105-118.
Zborowski M. Basic magnetic field configurations. In: Zborowski M, Chalmers JJ, eds. Magnetic
Cell Separation. Amsterdam, Netherlands: Elsevier; 2008:81-104.
Zborowski M. Magnetic formulary. In: Zborowski M, Chalmers JJ, eds. Magnetic Cell Separation.
Amsterdam, Netherlands: Elsevier; 2008:29-61.
Zborowski M, Moore LR, Melnik K, Jing Y. Worked examples of cell sample preparation and
magnetic separation procedures. In: Zborowski M, Chalmers JJ, eds. Magnetic Cell Separation.
Amsterdam, Netherlands: Elsevier; 2008:293-330.
Zbuk K, Stein J, Eng C. PTEN and Cowden syndrome. In: Isaacs C, Rebbeck TR, eds.
Hereditary Breast Cancer. New York, NY: Informa Healthcare; 2008:79-94.
Zhou M. Pathology of renal cell carcinomas. In: Bukowski RM, Novick AC, eds. Clinical
Management of Renal Tumors. Totowa, NJ: Humana Press; 2008:55-71.